5-Methoxy-N,N-dimethyltryptamine: An ego-dissolving endogenous neurochemical catalyst of creativity

IPFS icon-html5 HTML5 version icon-download PDF version  icon-text-height Plain text version    icon-link REST-style URL: http://5-meo-dmt.de

Abstract
5-Methoxy-N,N-dimethyltryptamine (acronymized as 5-MeO-DMT) is sui generis among the numerous naturally occurring psychoactive substances due to its unparalleled ego-dissolving effects which can culminate in a state of nondual consciousness that is phenomenologically similar to transformative peak experiences described in various ancient contemplative traditions (e.g., Advaita Vedānta, Mahāyāna Buddhism, inter alia). The enigmatic molecule is endogenous to the human brain and has profound psychological effects which are hitherto only very poorly understood due to the absence of scientifically controlled human experimental trials. Its exact neuronal receptor binding profile is a matter of ongoing research; however, empirical evidence indicates that its remarkable psychoactivity is partially mediated via agonism of the 5-HT1A/2A (serotonin) receptor subtypes. Anthropological/ethnopharmacological evidence indicates that various cultures utilized 5-MeO-DMT containing plants for medicinal, psychological, and spiritual purposes for millennia. We propose that this naturally occurring serotonergic compound could be fruitfully utilized as a neurochemical research tool with the potential to significantly advance our understanding of the psychological and neuronal processes which underpin cognition and creativity (e.g., downregulation of the default mode network, increased global functional connectivity, neuroplasticity, σ1 receptor interactions, etc.). An eclectic interdisciplinary perspective is adopted, and we present converging evidence from a plurality of sources in support of our conjecture. Specifically, we argue that 5-MeO-DMT has significant neuropsychopharmacological potential due to its incommensurable capacity to completely disintegrate self-referential cognitive/neuronal processes (viz., “ego death”). The importance of unbiased systematic scientific research on naturally occurring endogenous psychoactive compounds is discussed from a Jamesian radical empiricism perspective, and potential scenarios of abuse are addressed, particularly in the context of neuroethics, cybernetic manipulation, and military research on torture.

HTML5 full-text version (integrated AI text-to-speech synthesis):
icon-volume-up https://christopher-germann.de/papers/5-meo-dmt-creativity/index.html

Final version: https://link.springer.com/article/10.1007%2Fs41470-019-00063-y
DOI: https://doi.org/10.1007/s41470-019-00063-y

BioRxiv Preprint: https://www.biorxiv.org/content/10.1101/578435v2

QR code / Permanent URL & Citation export

URL: https://christopher-germann.de/5-methoxy-nn-dimethyltryptamine-an-ego-dissolving-endogenous-neurochemical-catalyst-of-creativity/
icon-pencil-square-o Citation tools


Molecular formula of 5-methoxy-N,N-dimethyltryptamine

Sherwood, A. M., Claveau, R., Lancelotta, R., Kaylo, K. W., & Lenoch, K.. (2020). Synthesis and Characterization of 5-MeO-DMT Succinate for Clinical Use. ACS Omega , 5(49), 32067–32075.

Plain numerical DOI: 10.1021/acsomega.0c05099
DOI URL
directSciHub download

See also: https://www.researchgate.net/publication/333320523_CLINICAL_CONSIDERATION_OF_5-MeO-DMT

5-methoxy-N,N-dimethyltryptamine
5-Meo-DMT
An enigmatic endogenous psychoactive tryptamine with profound psychological effects. Advancing the science of consciousness...
Incilius alvarius
Incilius alvarius
Structural similarities with serotonin

Serotonin
( 5-hydroxytryptamine)

5-MeO-DMT
(5-methoxy-N,N-dimethyltryptamine)

Structural similarities between serotonin (5-HT) and 5-MeO-DMT

More infos
The Swiss depth-psychologist Carl Gustav Jung

"There is no coming to consciousness without pain. People will do anything, no matter how absurd, in order to avoid facing their own Soul. One does not become enlightened by imagining figures of light, but by making the darkness conscious."
~ C.G. Jung

The Death of Socrates
Read more
William Blake - The doors of perception
Zoom
C.G. Jung - The Red Book
The book is freely available on the Internet Archive
Functional connectivity density (LSD vs. control)
Zoom
Tagliazucchi et al., 2016
Zoom
Multicriteria decision analysis of relative drug harm
Zoom
CogNovo, Marie Curie Actions
www.CogNovo.eu
Altmetric
Zoom
Breaking Conventions, University of Greenwich, London
Associated website
previous arrow
next arrow
 
5-methoxy-N,N-dimethyltryptamine
Incilius alvarius
Structural similarities with serotonin
The Swiss depth-psychologist Carl Gustav Jung
The Death of Socrates
William Blake - The doors of perception
C.G. Jung - The Red Book
Functional connectivity density (LSD vs. control)
Tagliazucchi et al., 2016
Multicriteria decision analysis of relative drug harm
CogNovo, Marie Curie Actions
Altmetric
Breaking Conventions, University of Greenwich, London
previous arrow
next arrow
Shadow
5-methoxy-N,N-dimethyltryptamine - An ego-dissolving endogenous neurochemical catalyst of creativity - christopher_b_germann_2019
BioRxiv Preprint

There is no coming to consciousness without pain. People will do anything, no matter how absurd, in order to avoid facing their own Soul. One does not become enlightened by imagining figures of light, but by making the darkness conscious. The latter procedure, however, is disagreeable and therefore not popular.
~ C.G. Jung

References
  1. Agurell, S., Holmstedt, B., Lindgren, J.-E., Schultes, R. E., Lindberg, A. A., Jansen, G., … Samuelsson, B. (1969). Alkaloids in certain species of Virola and other South American plants of ethnopharmacologic interest. Acta Chemica Scandinavica, 23, 903–916.Google Scholar
  2. Akers, B. P., Ruiz, J. F., Piper, A., & Ruck, C. A. P. (2011). A prehistoric mural in Spain depicting neurotropic psilocybe mushrooms? Economic Botany, 65(2), 121–128.CrossRefGoogle Scholar
  3. Alda, M., Puebla-Guedea, M., Rodero, B., Demarzo, M., Montero-Marin, J., Roca, M., & Garcia-Campayo, J. (2016). Zen meditation, length of telomeres, and the role of experiential avoidance and compassion. Mindfulness, 7(3), 651–659.CrossRefPubMedPubMedCentralGoogle Scholar
  4. al-Rifaie, M. M., Bishop, J. M., & Caines, S. (2012). Creativity and autonomy in swarm intelligence systems. Cognitive Computation, 4(3), 320–331.CrossRefGoogle Scholar
  5. Altvater, E. (2016). The capitalocene, or, geoengineering against capitalism’s planetary boundaries. In Anthropocene or capitalocene? Nature, history, and the crisis of capitalism. Oakland: PM Press.Google Scholar
  6. Amin, A. H., Crawford, T. B. B., & Gaddum, J. H. (1954). The distribution of substance P and 5-hydroxytryptamine in the central nervous system of the dog. Journal of Physiology, 596–618.Google Scholar
  7. Anderson, T., Petranker, R., Rosenbaum, D., Weissman, C. R., Dinh-Williams, L. A., Hui, K., … Farb, N. A. S. (2019). Microdosing psychedelics: personality, mental health, and creativity differences in microdosers. Psychopharmacology, 236(2), 731–740.Google Scholar
  8. Anjana, M. P. (2019). NEURALINK implantation of artificial intelligence in human beings. International Journal of Computer Sciences and Engineering.Google Scholar
  9. Anker, P. (2007). Buckminster Fuller as captain of spaceship earth. Minerva, 45(4), 417–434.CrossRefGoogle Scholar
  10. Anokhin, A. P., Golosheykin, S., Grant, J. D., & Heath, A. C. (2011). Heritability of delay discounting in adolescence: a longitudinal twin study. Behavior Genetics, 41(2), 175–183.CrossRefPubMedGoogle Scholar
  11. Armbrust, C., & Chomsky, N. (2005). Hegemony or survival: America’s quest for global dominance. The Antioch Review, 63(3), 594.CrossRefGoogle Scholar
  12. Arndt, J., & Vess, M. (2008). Tales from existential oceans: terror management theory and how the awareness of our mortality affects us all. Social and Personality Psychology Compass.Google Scholar
  13. Arquilla, J. (2011). From blitzkrieg to bitskrieg. Communications of the ACM, 54(10), 58.CrossRefGoogle Scholar
  14. Atmanspacher, H. (1997). Cartesian cut, Heisenberg cut, and the concept of complexity. World Futures, 49(3), 333–355.CrossRefGoogle Scholar
  15. Atmanspacher, H. (2012). Dual-aspect monism à la Pauli and Jung perforates the completeness of physics. In Journal of Consciousness Studies (pp. 5–21).Google Scholar
  16. Aziz, V. M., & Warner, N. J. (2005). Capgras’ syndrome of time. Psychopathology.Google Scholar
  17. Azmitia, E. C. (2012). Global projections of ancient aromatics neurotransmitters. In V. S. Ramachandran (Ed.), Encyclopedia of human behavior. Elsevier Science & Technology Books.Google Scholar
  18. Baas, M., Nevicka, B., & Ten Velden, F. S. (2014). Specific mindfulness skills differentially predict creative performance. Personality and Social Psychology Bulletin.Google Scholar
  19. Baird, J. C. (1997). Sensation and judgement: complementarity theory of psychophysics. Mahwah, NJ: Lawrence Erlbaum Associates.Google Scholar
  20. Baird, B., Smallwood, J., Mrazek, M. D., Kam, J. W. Y., Franklin, M. S., & Schooler, J. W. (2012). Inspired by distraction. Psychological Science, 23(10), 1117–1122.CrossRefPubMedGoogle Scholar
  21. Bamford, J. (2001). Body of secrets: anatomy of the ultra-secret National Security Agency: from the Cold War through the dawn of a new century. Doubleday.Google Scholar
  22. Barker, S. A., Borjigin, J., Lomnicka, I., & Strassman, R. (2013). LC/MS/MS analysis of the endogenous dimethyltryptamine hallucinogens, their precursors, and major metabolites in rat pineal gland microdialysate. Biomedical Chromatography, 27(12), 1690–1700.CrossRefPubMedGoogle Scholar
  23. Barnosky, A. D., Matzke, N., Tomiya, S., Wogan, G. O. U., Swartz, B., Quental, T. B., … Ferrer, E. A. (2011). Has the Earth’s sixth mass extinction already arrived? Nature.Google Scholar
  24. Barrett, F. S., Johnson, M. W., & Griffiths, R. R. (2015). Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin. Journal of Psychopharmacology, 29(11), 1182–1190.CrossRefPubMedGoogle Scholar
  25. Barrett, F. S., Bradstreet, M. P., Leoutsakos, J.-M. S., Johnson, M. W., & Griffiths, R. R. (2016). The Challenging Experience Questionnaire: characterization of challenging experiences with psilocybin mushrooms. Journal of Psychopharmacology, 30(12), 1279–1295.CrossRefPubMedGoogle Scholar
  26. Barsuglia, J. P., Polanco, M., Palmer, R., Malcolm, B. J., Kelmendi, B., & Calvey, T. (2018). A case report SPECT study and theoretical rationale for the sequential administration of ibogaine and 5-MeO-DMT in the treatment of alcohol use disorder. In Progress in Brain Research (pp. 121–158).Google Scholar
  27. Baudrillard, J. (1998). The consumer society: myths and structures. Sage.Google Scholar
  28. Baudrillard, J., & Lotringer, S. (2005). The conspiracy of art: manifestos, interviews, essays. Semiotext(e).Google Scholar
  29. Bauman, Z., Bigo, D., Esteves, P., Guild, E., Jabri, V., Lyon, D., & Walker, R. B. J. (2014). After Snowden: rethinking the impact of surveillance. International Political Sociology.Google Scholar
  30. Baumeister, R. F., & Leary, M. R. (1995). The need to belong: desire for interpersonal attachments as a fundamental human motivation. Psychological Bulletin, 117(3), 497–529.CrossRefPubMedGoogle Scholar
  31. Baumeister, R. F., Vohs, K. D., & Tice, D. M. (2007). The strength model of self-control. Current Directions in Psychological Science, 16(6), 351–355.CrossRefGoogle Scholar
  32. Beaty, R. E., Benedek, M., Silvia, P. J., & Schacter, D. L. (2016). Creative cognition and brain network dynamics. Trends in Cognitive Sciences, 20(2), 87–95.CrossRefPubMedGoogle Scholar
  33. Beaty, R. E., Kenett, Y. N., Christensen, A. P., Rosenberg, M. D., Benedek, M., Chen, Q., … Silvia, P. J. (2018). Robust prediction of individual creative ability from brain functional connectivity. Proceedings of the National Academy of Sciences, 115(5), 1087–1092.Google Scholar
  34. Benedek, M., Könen, T., & Neubauer, A. C. (2012). Associative abilities underlying creativity. Psychology of Aesthetics, Creativity, and the Arts, 6(3), 273–281.CrossRefGoogle Scholar
  35. Benoit, J., Abdala, F., Manger, P., & Rubidge, B. (2016). The sixth sense in mammalians forerunners: variability of the parietal foramen and the evolution of the pineal eye in South African Permo-Triassic eutheriodont therapsids. Acta Palaeontologica Polonica.Google Scholar
  36. Bentley, P. J., & Corne, D. W. (2002). An introduction to creative evolutionary systems. In Creative evolutionary systems (pp. 1–75). Elsevier.Google Scholar
  37. Bernays, E. L. (1928). Propaganda. Horace Liveright.Google Scholar
  38. Berra, T. M., Alvarez, G., & Shannon, K. (2010). The Galton-Darwin-Wedgwood pedigree of H. H. Laughlin. Biological Journal of the Linnean Society, 101(1), 228–241.CrossRefGoogle Scholar
  39. Beucke, J. C., Sepulcre, J., Eldaief, M. C., Sebold, M., Kathmann, N., & Kaufmann, C. (2014). Default mode network subsystem alterations in obsessive-compulsive disorder. British Journal of Psychiatry.Google Scholar
  40. Biehl-Missal, B., & Saren, M. (2012). Atmospheres of seduction: a critique of aesthetic marketing practices. Journal of Macromarketing.Google Scholar
  41. Bizzotto, J. (2018). The hypothesis on the presence of entheogens in the Eleusinian mysteries. Medicina Historica, 2(2), 85–93.Google Scholar
  42. Blechner, M. J. (2001). The dream frontier. Analytic Press.Google Scholar
  43. Block, N., & Stalnaker, R. (1999). Conceptual analysis, dualism, and the explanatory gap. The Philosophical Review, 108(1), 1.CrossRefGoogle Scholar
  44. Bob, P., & Louchakova, O. (2015). Dissociative states in dreams and brain chaos: implications for creative awareness. Frontiers in Psychology, 6.Google Scholar
  45. Boden, M. A. (2014). Creativity and artificial intelligence. In The philosophy of creativity (pp. 224–244). Oxford University Press.Google Scholar
  46. Bogenschutz, M. P., & Forcehimes, A. A. (2017). Development of a psychotherapeutic model for psilocybin-assisted treatment of alcoholism. Journal of Humanistic Psychology.Google Scholar
  47. Bogenschutz, M. P., & Johnson, M. W. (2016). Classic hallucinogens in the treatment of addictions. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 64, 250–258.CrossRefPubMedGoogle Scholar
  48. Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A., Wilcox, C. E., Barbosa, P. C. R., & Strassman, R. J. (2015). Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. Journal of Psychopharmacology, 29(3), 289–299.CrossRefPubMedGoogle Scholar
  49. Bohannon, J. (2015). Fears of an AI pioneer. Science, 349(6245), 252–252.CrossRefPubMedGoogle Scholar
  50. Boire, R. (2000). On cognitive liberty. Journal of Cognitive Liberties, 1(1), 1–26.Google Scholar
  51. Bolstridge, M. (2013). The psychedelic Renaissance: reassessing the role of psychedelic drugs in 21st century psychiatry and society. The British Journal of Psychiatry, 202(3), 239–239.CrossRefGoogle Scholar
  52. Bourdieu, P. (1977). Outline of a theory of practice. Cambridge University Press.Google Scholar
  53. Brecher, B. (2008). Torture and the ticking bomb.Google Scholar
  54. Breggin, P. R. (1998). Electroshock: scientific, ethical, and political issues. International Journal of Risk & Safety in Medicine.Google Scholar
  55. Breggin, P. R. (2003). Psychopharmacology and human values. Journal of Humanistic Psychology, 43(2), 34–49.CrossRefGoogle Scholar
  56. Breggin, P. R. (2008). Brain-disabling treatments in psychiatry: drugs, electroshock, and the psychopharmaceutical complex (2nd ed.). Springer.Google Scholar
  57. Breggin, P. R. (2011). Psychiatric drug-induced chronic brain impairment (CBI): implications for long-term treatment with psychiatric medication. International Journal of Risk and Safety in Medicine, 23(4), 193–200.PubMedGoogle Scholar
  58. Breggin, P. R. (2016). Rational principles of psychopharmacology for therapists, healthcare providers and clients. Journal of Contemporary Psychotherapy, 46(1), 1–13.CrossRefGoogle Scholar
  59. Breggin, P. R., & Breggin, G. R. (1996). The hazards of treating “attention-deficit/hyperactivity disorder” with methylphenidate (Ritalin). Journal of College Student Psychotherapy, 10(2), 55–72.CrossRefGoogle Scholar
  60. Brewer, J. A., Worhunsky, P. D., Gray, J. R., Tang, Y.-Y., Weber, J., & Kober, H. (2011). Meditation experience is associated with differences in default mode network activity and connectivity. Proceedings of the National Academy of Sciences. Google Scholar
  61. Brown, R. E. (2007). Alfred McCoy, Hebb, the CIA and torture. Journal of the History of the Behavioral Sciences, 43(2), 205–213.CrossRefPubMedGoogle Scholar
  62. Brzezinski, Z. (1997). The grand chessboard: American primacy and its geostrategic imperatives. BasicBooks.Google Scholar
  63. Burch, G. S. J., Hemsley, D. R., Pavelis, C., & Corr, P. J. (2006). Personality, creativity and latent inhibition. European Journal of Personality, 20(2), 107–122.CrossRefGoogle Scholar
  64. Burgarth, D., Facchi, P., Giovannetti, V., Nakazato, H., Pascazio, S., & Yuasa, K. (2014). Quantum computing in Plato’s cave.Google Scholar
  65. Burnyeat, M. (2000). Plato on why mathematics is good for the soul. Proceedings of the British Academy, 103, 1–83.Google Scholar
  66. Byron, K., Khazanchi, S., & Nazarian, D. (2010). The relationship between stressors and creativity: a meta-analysis examining competing theoretical models. Journal of Applied Psychology, 95(1), 201–212.CrossRefPubMedGoogle Scholar
  67. Callaway, J. C., Grob, C. S., McKenna, D. J., Nichols, D. E., Shulgins, A., & Tupper, K. W. (2006). A demand for clarity regarding a case report on the ingestion of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in an ayahuasca preparation. Journal of Analytical Toxicology, 30(6), 406–407.CrossRefPubMedGoogle Scholar
  68. Cameron, L. P., & Olson, D. E. (2018). Dark classics in chemical neuroscience: N,N-dimethyltryptamine (DMT). ACS Chemical Neuroscience.Google Scholar
  69. Capurso, V., Fabbro, F., & Crescentini, C. (2014). Mindful creativity: the influence of mindfulness meditation on creative thinking. Frontiers in Psychology, 4.Google Scholar
  70. Carbonaro, T. M., & Gatch, M. B. (2016). Neuropharmacology of N,N-dimethyltryptamine. Brain Research Bulletin, 126(1), 74–88.CrossRefPubMedPubMedCentralGoogle Scholar
  71. Carhart-Harris, R. L., & Nutt, D. (2017). Serotonin and brain function: a tale of two receptors. Journal of Psychopharmacology, 31(9), 1091–1120.CrossRefPubMedGoogle Scholar
  72. Carhart-Harris, R. L., Erritzoe, D., Williams, T., Stone, J. M., Reed, L. J., Colasanti, A., et al. (2012). Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. Proceedings of the National Academy of Sciences of the United States of America, 109(6), 2138–2143.CrossRefPubMedPubMedCentralGoogle Scholar
  73. Carhart-Harris, R. L., Leech, R., Hellyer, P. J., Shanahan, M., Feilding, A., Tagliazucchi, E., et al. (2014). The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs. Frontiers in Human Neuroscience, 8(2), 20.PubMedPubMedCentralGoogle Scholar
  74. Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M. J., Erritzoe, D., Kaelen, M., … Nutt, D. J. (2016). Psilocybin with pyschological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry, 3(7), 619–627.Google Scholar
  75. Carhart-Harris, R. L., Roseman, L., Bolstridge, M., Demetriou, L., Pannekoek, J. N., Wall, M. B., et al. (2017). Psilocybin for treatment-resistant depression: FMRI-measured brain mechanisms. Scientific Reports, 7(1), 13187.CrossRefPubMedPubMedCentralGoogle Scholar
  76. Carhart-Harris, R. L., Erritzoe, D., Haijen, E., Kaelen, M., & Watts, R. (2018). Psychedelics and connectedness. Psychopharmacology, 235(2), 547–550.CrossRefPubMedGoogle Scholar
  77. Carlozzi, A. F., Bull, K. S., Eells, G. T., & Hurlburt, J. D. (1995). Empathy as related to creativity, dogmatism, and expressiveness. Journal of Psychology: Interdisciplinary and Applied.Google Scholar
  78. Cartwright, J. H. E., & González, D. L. (2016). Möbius strips before Möbius: topological hints in ancient representations. Mathematical Intelligencer.Google Scholar
  79. Casey, G., & Moran, A. (1989). The computational metaphor and cognitive psychology. The Irish Journal of Psychology.Google Scholar
  80. Casselman, I., Nock, C. J., Wohlmuth, H., Weatherby, R. P., & Heinrich, M. (2014). From local to global—fifty years of research on Salvia divinorum. Journal of Ethnopharmacology, 151(2), 768–783.CrossRefPubMedGoogle Scholar
  81. Catlow, B. J., Song, S., Paredes, D. A., Kirstein, C. L., & Sanchez-Ramos, J. (2013). Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning. Experimental Brain Research, 228(4), 481–491.CrossRefPubMedGoogle Scholar
  82. Cavanna, A. E. (2007). The precuneus and consciousness. CNS Spectrums, 12(7), 545–552.CrossRefPubMedGoogle Scholar
  83. Ceballos, G., & Ehrlich, P. R. (2018). The misunderstood sixth mass extinction. Science.Google Scholar
  84. Ceballos, G., Ehrlich, P. R., & Dirzo, R. (2017). Biological annihilation via the ongoing sixth mass extinction signaled by vertebrate population losses and declines. Proceedings of the National Academy of Sciences.Google Scholar
  85. Chakravartty, P., & Schiller, D. a. N. (2010). Neoliberal newspeak and digital capitalism in crisis. International Journal of Communication, 4, 670–692.Google Scholar
  86. Chalmers, D. J. (1995). Facing up to the problem of consciousness. Journal of Conscious Studies, 2(3), 200–219.Google Scholar
  87. Chase, A. (2000). Harvard and the making of the unabomber. The Atlantic, 285(6), 41–63.Google Scholar
  88. Chen, A. L., & Chen, K. K. (1939). Harmine, the alkaloid of caapi. Quarterly Journal of Pharmacy and Pharmacology.Google Scholar
  89. Chen, T.-S., Liou, S.-Y., & Chang, Y.-L. (2008). Antioxidant evaluation of three adaptogen extracts. The American Journal of Chinese Medicine.Google Scholar
  90. Chen, Y., Ozturk, N. C., & Zhou, F. C. (2013). DNA methylation program in developing hippocampus and its alteration by alcohol. PLoS One, 8(3).Google Scholar
  91. Chomsky, N. (1992). Manufacturing consent: Noam Chomsky and the media. East.Google Scholar
  92. Chomsky, N. (2015). Academic freedom and the subservience to power. In Who’s afraid of academic freedom? Google Scholar
  93. Chomsky, N. (2016). Who rules the world? Hamish Hamilton.Google Scholar
  94. Claridge, G., & Blakey, S. (2009). Schizotypy and affective temperament: relationships with divergent thinking and creativity styles. Personality and Individual Differences, 46(8), 820–826.CrossRefGoogle Scholar
  95. Coleman, J. (2005). The corporation—the pathological pursuit of power and profit. European Business Review, 17(5), ebr.2005.05417eab.005.CrossRefGoogle Scholar
  96. Colzato, L. S., Ozturk, A., & Hommel, B. (2012). Meditate to create: the impact of focused-attention and open-monitoring training on convergent and divergent thinking. Frontiers in Psychology, 3.Google Scholar
  97. Comai, S., Bertazzo, A., Carretti, N., Podfigurna-Stopa, A., Luisi, S., & Costa, C. V. L. (2010). Serum levels of tryptophan, 5-hydroxytryptophan and serotonin in patients affected with different forms of amenorrhea. International Journal of Tryptophan Research, 3, IJTR.S3804.CrossRefGoogle Scholar
  98. Comfort, A. (1979). The Cartesian observer revisited: ontological implications of the homuncular illusion. Journal of Social and Biological Systems, 2(3), 211–223.CrossRefGoogle Scholar
  99. Cooper, N. (1966). The importance of Δianoia in Plato’s theory of forms. The Classical Quarterly, 16(1), 65–69.CrossRefGoogle Scholar
  100. Cozzi, N. V. (2013). Psychedelic breakthroughs in neuroscience: how psychedelic drugs influenced the growth and development of psychopharmacology. MAPS Special Bulletin.Google Scholar
  101. Crick, F. (1970). Central dogma of molecular biology. Nature.Google Scholar
  102. Cropley, D. H., Cropley, A. J., Kaufman, J. C., & Runco, M. A. (2010). In D. H. Cropley, A. J. Cropley, J. C. Kaufman, & M. A. Runco (Eds.), The dark side of creativity. Cambridge: Cambridge University Press.CrossRefGoogle Scholar
  103. d’Inverno, M., & Luck, M. (2012). Creativity through autonomy and interaction. Cognitive Computation, 4(3), 332–346.CrossRefGoogle Scholar
  104. Da Lee, R., Mi An, S., Sun Kim, S., Seek Rhee, G., Jun Kwack, S., Hyun Seok, J., … Lea Park, K. (2005). Neurotoxic effects of alcohol and acetaldehyde during embryonic development. Journal of Toxicology and Environmental Health, Part A, 68(23–24), 2147–2162.Google Scholar
  105. Dakic, V. (2017). Short term changes in the proteome of human cerebral organoids induced by 5-methoxy-N,N-dimethyltryptamine. BIoRxlv.Google Scholar
  106. Dakic, V., Minardi Nascimento, J., Costa Sartore, R., Maciel, R. de M., de Araujo, D. B., Ribeiro, S., … Rehen, S. K. (2017). Short term changes in the proteome of human cerebral organoids induced by 5-MeO-DMT. Scientific Reports, 7(1), 12863.Google Scholar
  107. Davis, J. V., & Canty, J. M. (2013). Ecopsychology and transpersonal psychology. In The Wiley-Blackwell handbook of transpersonal psychology (Vol. 30, pp. 595–611). Chichester: John Wiley & Sons, Ltd.CrossRefGoogle Scholar
  108. Davis, W., & Weil, A. T. (1992). Identity of a New World psychoactive toad. Ancient Mesoamerica, 3(1), 51–59.CrossRefGoogle Scholar
  109. Dawson, J. (2004). Reflectivity, creativity, and the space for silence. Reflective Practice.Google Scholar
  110. DeFries, R., & Nagendra, H. (2017). Ecosystem management as a wicked problem. Science, 356(6335), 265–270.CrossRefPubMedGoogle Scholar
  111. Delgado, J. M. R. (1964). Free behavior and brain stimulation. In International Review of Neurobiology (pp. 349–449).Google Scholar
  112. Delgado, J. M. R., & Hamlin, H. (1956). Surface and depth electrography of the frontal lobes in conscious patients. Electroencephalography and Clinical Neurophysiology, 8(3), 371–384.CrossRefPubMedGoogle Scholar
  113. DeScioli, P., Christner, J., & Kurzban, R. (2011). The omission strategy. Psychological Science, 22(4), 442–446.CrossRefPubMedGoogle Scholar
  114. Deussen, P. (1906). The philosophy of the Upanishads. Cosimo Classics.Google Scholar
  115. DeYoung, C. G., Peterson, J. B., & Higgins, D. M. (2005). Sources of openness/intellect: cognitive and neuropsychological correlates of the fifth factor of personality. Journal of Personality, 73(4), 825–858.CrossRefPubMedGoogle Scholar
  116. Dias, B. G., & Ressler, K. J. (2014). Parental olfactory experience influences behavior and neural structure in subsequent generations. Nature Neuroscience, 17(1), 89–96.CrossRefPubMedGoogle Scholar
  117. Dietz, T., Rosa, E. A., & York, R. (2007). Driving the human ecological footprint. Frontiers in Ecology and the Environment.Google Scholar
  118. Ding, X., Tang, Y. Y., Tang, R., & Posner, M. I. (2014). Improving creativity performance by short-term meditation. Behavioral and Brain Functions.Google Scholar
  119. Domhoff, G. (1975). New directions in power structure research (Worn edition). The Insurgent Sociologist.Google Scholar
  120. Domino, G. (1976). Transcendental meditation and creativity: an empirical investigation. Journal of Applied Psychology.Google Scholar
  121. Douglas, A., & Pond, C. (2012). America’s war on drugs and the prison-industrial complex. Gender Race & Justice, 417.Google Scholar
  122. Eakin, R. M., & Westfall, J. A. (1959). Fine structure of the retina in the reptilian third eye. The Journal of Cell Biology.Google Scholar
  123. Eddington, A. S. (1929). The nature of the physical world. Book.Google Scholar
  124. Eddington, A. S. (1938). The philosophy of physical science. Cambridge University Press.Google Scholar
  125. Elliston, J. (1999). Psywar on Cuba: the declassified history of U.S. anti-Castro propaganda. Ocean Press.Google Scholar
  126. Ellul, J. (1973). Propaganda: the formation of men’s attitudes. Vintage Books.Google Scholar
  127. El-Seedi, H. R., De Smet, P. A. G. M., Beck, O., Possnert, G., & Bruhn, J. G. (2005). Prehistoric peyote use: alkaloid analysis and radiocarbon dating of archaeological specimens of Lophophora from Texas. Journal of Ethnopharmacology.Google Scholar
  128. Epel, E., Daubenmier, J., Moskowitz, J. T., Folkman, S., & Blackburn, E. (2009). Can meditation slow rate of cellular aging? Cognitive stress, mindfulness, and telomeres. Annals of the New York Academy of Sciences, 1172(1), 34–53.CrossRefPubMedPubMedCentralGoogle Scholar
  129. Erspamer, V., Vitali, T., Roseghini, M., & Cei, J. M. (1965). 5-Methoxy- and 5-hydroxy-indolealkylamines in the skin of Bufo alvarius. Experientia, 21(9), 504.CrossRefPubMedGoogle Scholar
  130. Evans, J. S. B. T., Over, D. E., & Manktelow, K. I. (1993). Reasoning, decision making and rationality. Cognition.Google Scholar
  131. Farah, M. J. (2005). Neuroethics: The practical and the philosophical. Trends in Cognitive Sciences.Google Scholar
  132. Faust, M., & Kenett, Y. N. (2014). Rigidity, chaos and integration: hemispheric interaction and individual differences in metaphor comprehension. Frontiers in Human Neuroscience, 8.Google Scholar
  133. Feist, G. J. (1998). A meta-analysis of personality in scientific and artistic creativity. Personality and Social Psychology Review, 2(4), 290–309.CrossRefPubMedGoogle Scholar
  134. Festinger, L. (1957). A theory of cognitive dissonance. Scientific American.Google Scholar
  135. Fleming, P., & Oswick, C. (2014). Educating consent? A conversation with Noam Chomsky on the university and business school education. Organization, 21(4), 568–578.CrossRefGoogle Scholar
  136. Fleming, S. M., Thomas, C. L., & Dolan, R. J. (2010). Overcoming status quo bias in the human brain. Proceedings of the National Academy of Sciences, 107(13), 6005–6009.CrossRefGoogle Scholar
  137. Forgeard, M. J. C. (2013). Perceiving benefits after adversity: the relationship between self-reported posttraumatic growth and creativity. Psychology of Aesthetics, Creativity, and the Arts, 7(3), 245–264.CrossRefGoogle Scholar
  138. Forstmann, M., & Sagioglou, C. (2017). Lifetime experience with (classic) psychedelics predicts pro-environmental behavior through an increase in nature relatedness. Journal of Psychopharmacology, 31(8), 975–988.CrossRefPubMedGoogle Scholar
  139. Foster, J. B., & Holleman, H. (2014). The financial power elite. Monthly Review.Google Scholar
  140. Francesc Alonso, J., Romero, S., Angel Mañanas, M., & Riba, J. (2015). Serotonergic psychedelics temporarily modify information transfer in humans. International Journal of Neuropsychopharmacology, 18(8), 1–9.Google Scholar
  141. Frecska, E., Bokor, P., & Winkelman, M. (2016). The therapeutic potentials of ayahuasca: possible effects against various diseases of civilization. Frontiers in Pharmacology, 7.Google Scholar
  142. Frederking, W. (1955). Intoxicant drugs (mescaline and lysergic acid diethylamide) in psychotherapy. The Journal of Nervous and Mental Disease, 121(3), 262–266.CrossRefPubMedGoogle Scholar
  143. Freedman, J. L., & Fraser, S. C. (2017). Social psychology in natural settings. Social psychology in natural settings: a reader in field experimentation. Routledge.Google Scholar
  144. Freud, S. (1923). The ego and the id. The standard edition of the complete psychological works of Sigmund Freud, Volume XIX (1923–1925): the ego and the id and other works, 19–27.Google Scholar
  145. Freud, S. (1930). Civilisation and Its Discontents. In The standard edition of the complete psychological works of Sigmund Freud—the future of an illusion, civilization and its discontents, and other works.Google Scholar
  146. Freud, S. (1939). Die Traumdeutung. Leipzig und Wien: Franz Deuticke.Google Scholar
  147. Fromm, E. (1962). Beyond the chains of illusion: my encounter with Marx and Freud. Continuum.Google Scholar
  148. Fromm, E. (1976). To have or to be? Bloomsbury.Google Scholar
  149. Froud, J., Johal, S., Moran, M., & Williams, K. (2017). Outsourcing the state: new sources of elite power. Theory, Culture & Society, 34(5–6), 77–101.CrossRefGoogle Scholar
  150. Fuller, R. B. (1981). Critical path. St. Martin’s Press.Google Scholar
  151. Furst, P. T. (1972). Symbolism and psychopharmacology: the toad as Earth Mother in Indian America. In K. J. Litrak & T. N. Castillo (Eds.), 1972, Religión en MesoamericaXII Mesa Redonda (pp. 37–46). México: Sociedad Méxicana de Antropología.Google Scholar
  152. Gable, R. S. (1993). Toward a comparative overview of dependence potential and acute toxicity of psychoactive substances used nonmedically. The American Journal of Drug and Alcohol Abuse, 19(3), 263–281.CrossRefPubMedGoogle Scholar
  153. Gaddum, J. H., & Hameed, K. A. (1954). Drugs which antagonize 5-hydroxytryptamine. British Journal of Pharmacology, 240–248.Google Scholar
  154. Geerling, W., Magee, G. B., & Brooks, R. (2015). Cooperation, defection and resistance in Nazi Germany. Explorations in Economic History, 58, 125–139.CrossRefGoogle Scholar
  155. Gentry, C. (1991). J. Edgar Hoover: the man and the secrets. Norton.Google Scholar
  156. Gillis, J. (1966). Auguste Kekulé et son oeuvre, réalisée à Gand de 1858 à 1867. Bruxelles: Palais des académies.Google Scholar
  157. Gilmore, R. W. (1999). Globalisation and US prison growth: from military Keynesianism to post-Keynesian militarism. Race & Class, 40(2–3), 171–188.CrossRefGoogle Scholar
  158. Gino, F., & Ariely, D. (2012). The dark side of creativity: original thinkers can be more dishonest. Journal of Personality and Social Psychology.Google Scholar
  159. Gino, F., & Wiltermuth, S. S. (2014). Evil genius? How dishonesty can lead to greater creativity. Psychological Science.Google Scholar
  160. Giroux, H. A. (2015). University in chains. University in chains: confronting the military-industrial-academic complex. Routledge.Google Scholar
  161. Glennon, R. A., & Rosecrans, J. A. (1982). Indolealkylamine and phenalkylamine hallucinogens: a brief overview. In Neuroscience and Biobehavioral Reviews.Google Scholar
  162. Glick, S. D., & Maisonneuve, I. M. (1998). Mechanisms of antiaddictive actions of ibogaine. In Annals of the New York Academy of Sciences (Vol. 844, pp. 214–226).Google Scholar
  163. Glisky, M. L., Tataryn, D. J., Tobias, B. A., Kihlstrom, J. F., & McConkey, K. M. (1991). Absorption, openness to experience, and hypnotizability. Journal of Personality and Social Psychology, 60(2), 263–272.CrossRefPubMedGoogle Scholar
  164. Goel, V., & Dolan, R. J. (2001). Functional neuroanatomy of three-term relational reasoning. Neuropsychologia.Google Scholar
  165. Goel, V., Gold, B., Kapur, S., & Houle, S. (1998). Neuroanatomical correlates of human reasoning. Journal of Cognitive Neuroscience.Google Scholar
  166. Gormley, K. (2018). Neoliberalism and the discursive construction of ‘creativity’. Critical Studies in Education, 1–16.Google Scholar
  167. Grady, B., & Loewenthal, K. M. (1997). Features associated with speaking in tongues (glossolalia). British Journal of Medical Psychology.Google Scholar
  168. Grant, R. M. (1996). Irenaeus of Lyons, 169.Google Scholar
  169. Gregg, A. P., Mahadevan, N., & Sedikides, C. (2017). Intellectual arrogance and intellectual humility: correlational evidence for an evolutionary-embodied-epistemological account. Journal of Positive Psychology, 12(1), 59–73.CrossRefGoogle Scholar
  170. Grey, A. (2001). Transfigurations. Rochester, VT: Inner Traditions.Google Scholar
  171. Griffiths, R. R., Richards, W. A., McCann, U., & Jesse, R. (2006). Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology, 187(3), 268–283.CrossRefPubMedGoogle Scholar
  172. Griffiths, R. R., Richards, W., Johnson, M., McCann, U., & Jesse, R. (2008). Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. Journal of Psychopharmacology (Oxford, England), 22(6), 621–632.CrossRefGoogle Scholar
  173. Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., … Klinedinst, M. A. (2016). Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial. Journal of Psychopharmacology, 30(12), 1181–1197.Google Scholar
  174. Gröblacher, S., Paterek, T., Kaltenbaek, R., Brukner, Č., Zukowski, M., Aspelmeyer, M., & Zeilinger, A. (2007). An experimental test of non-local realism. Nature.Google Scholar
  175. Grof, S. (2000). LSD-Psychotherapie. Stuttgart: Klett-Cotta.Google Scholar
  176. Gruner, P., & Pittenger, C. (2017). Cognitive inflexibility in obsessive-compulsive disorder. Neuroscience, 345, 243–255.CrossRefPubMedGoogle Scholar
  177. Guglielmi, G. (2018). Doomsday clock now only two minutes to Armageddon. Nature 2018.Google Scholar
  178. Guiltinan, J. (2009). Creative destruction and destructive creations: environmental ethics and planned obsolescence. Journal of Business Ethics.Google Scholar
  179. Halberstadt, A. L. (2016). Behavioral and pharmacokinetic interactions between monoamine oxidase inhibitors and the hallucinogen 5-methoxy-N,N-dimethyltryptamine. Pharmacology Biochemistry and Behavior, 143, 1–10.CrossRefGoogle Scholar
  180. Halpern, J. H., Lerner, A. G., & Passie, T. (2016). A review of hallucinogen persisting perception disorder (HPPD) and an exploratory study of subjects claiming symptoms of HPPD. In Current Topics in Behavioral Neurosciences (pp. 333–360).Google Scholar
  181. Hameroff, S., & Penrose, R. (2014). Consciousness in the universe: a review of the Orch OR theory. Physics of Life Reviews, 11(1), 39–78.CrossRefPubMedGoogle Scholar
  182. Handsteiner, J., Friedman, A. S., Rauch, D., Gallicchio, J., Liu, B., Hosp, H., … Zeilinger, A. (2017). Cosmic bell test: measurement settings from Milky Way stars. Physical Review Letters, 118(6).Google Scholar
  183. Hariri, A. R. (2002). Serotonin transporter genetic variation and the response of the human amygdala. Science, 297(5580), 400–403.CrossRefPubMedGoogle Scholar
  184. Harman, W. W., McKim, R. H., Mogar, R. E., Fadiman, J., & Stolaroff, M. J. (1966). Psychedelic agents in creative problem-solving: a pilot study. Psychological Reports, 19(1), 211–227.CrossRefPubMedGoogle Scholar
  185. Hartmann, E., Rosen, R., & Rand, W. (1998). Personality and dreaming: boundary structure and dream content. Dreaming.Google Scholar
  186. Harvey, D. (2007). Neoliberalism as creative destruction. The ANNALS of the American Academy of Political and Social Science, 610(1), 21–44.CrossRefGoogle Scholar
  187. Heal, D. J., Smith, S. L., Gosden, J., & Nutt, D. J. (2013). Amphetamine, past and present—a pharmacological and clinical perspective. Journal of Psychopharmacology.Google Scholar
  188. Heard, E., & Martienssen, R. A. (2014). Transgenerational epigenetic inheritance: myths and mechanisms. Cell.Google Scholar
  189. Hebb, D. O. (1949). The organization of behavior. The Organization of Behavior, 911(1), 335.Google Scholar
  190. Heinz, A., Braus, D. F., Smolka, M. N., Wrase, J., Puls, I., Hermann, D., … Büchel, C. (2005). Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter. Nature Neuroscience.Google Scholar
  191. Hermanns, W., & Einstein, A. (1983). Einstein and the poet: in search of the cosmic man.Google Scholar
  192. Hesslow, G. (2012). The current status of the simulation theory of cognition. Brain Research, 1428, 71–79.CrossRefPubMedGoogle Scholar
  193. Hill, D., & Kumar, R. (2009). Global neoliberalism and education and its consequences. Routledge.Google Scholar
  194. Hiriyanna, M. (1995). The essentials of Indian philosophy. Motilal Banarsidass Publishers.Google Scholar
  195. Hoffman, D. D. (2016). The interface theory of perception. Current Directions in Psychological Science, 25(3), 157–161.CrossRefGoogle Scholar
  196. Hofmann, A., & Troxler, F. (1959). Identifizierung von Psilocin. Experientia, 15(3), 101–102.CrossRefPubMedGoogle Scholar
  197. Hofmann, A., Frey, A., Ott, H., Petrzilka, T., & Troxler, F. (1958a). Elucidation of the structure and the synthesis of psilocybin. Experientia, 14(11), 397–399.CrossRefPubMedGoogle Scholar
  198. Hofmann, A., Heim, R., Brack, A., & Kobel, H. (1958b). Psilocybin, ein psychotroper Wirkstoff aus dem mexikanischen Rauschpilz Psilocybe mexicana Heim. Experientia.Google Scholar
  199. Hofmann, A., Heim, R., Brack, A., Kobel, H., Frey, H., Ott, H., … Troxler, F. (1959). Psilocybin und Psilocin, zwei psychotrope Wirkstoffe aus mexikanischen Rauschpilzen. Helvetica Chimica Acta, 42, 1557–1572.Google Scholar
  200. Hofstede, G. (2011). Dimensionalizing cultures: the Hofstede model in context. Online Readings in Psychology and Culture, 2(1).Google Scholar
  201. Holder, R. D. (2002). Fine-tuning, multiple universes and theism. Noûs, 36(2), 295–312.CrossRefGoogle Scholar
  202. Horan, R. (2009). The neuropsychological connection between creativity and meditation. Creativity Research Journal, 21(2–3), 199–222.CrossRefGoogle Scholar
  203. Hornung, J.-P. (2003). The human raphe nuclei and the serotonergic system. Journal of Chemical Neuroanatomy, 26(4), 331–343.CrossRefPubMedGoogle Scholar
  204. Hoshino, T., & Shimodaira, K. (1936). Über die Synthese des Bufotenin-Methyl-Äthers (5-Methoxy-N-Dimethyl-Tryptamin) und Bufotenins. Synthesen in der Indol-Gruppe. XV. Bulletin of the Chemical Society of Japan, 11(3), 221–224.CrossRefGoogle Scholar
  205. Hutchinson, D. A., & Savitzky, A. H. (2004). Vasculature of the parotoid glands of four species of toads (Bufonidae: Bufo). Journal of Morphology, 260(2), 247–254.CrossRefPubMedGoogle Scholar
  206. Huxley, A. (1954). The doors of perception and heaven and hell. London: Harper & Brothers.Google Scholar
  207. Hwang, J., Kim, S., & Lee, D. (2009). Temporal discounting and inter-temporal choice in rhesus monkeys. Frontiers in Behavioral Neuroscience, 3, 9.PubMedPubMedCentralGoogle Scholar
  208. Ivcevic, Z., & Brackett, M. A. (2015). Predicting creativity: interactive effects of openness to experience and emotion regulation ability. Psychology of Aesthetics, Creativity, and the Arts, 9(4), 480–487.CrossRefGoogle Scholar
  209. Jackson, F. (1986). What Mary didn’t know. The Journal of Philosophy, 83(5), 291–295.CrossRefGoogle Scholar
  210. Jacobsen, A. (2014). Operation Paperclip: the secret intelligence program to bring Nazi scientists to America. Little, Brown and Company.Google Scholar
  211. Jacobsen, A. (2015). The Pentagon’s brain: an uncensored history of DARPA, America’s top secret military research agency. Little, Brown US.Google Scholar
  212. Jacobsen, A. (2017). Phenomena: the secret history of the U.S. government’s investigations into extrasensory perception and psychokinesis. Little, Brown and Company.Google Scholar
  213. Jacobus, J., & Tapert, S. F. (2013). Neurotoxic effects of alcohol in adolescence. Annual Review of Clinical Psychology, 9(1), 703–721.CrossRefPubMedGoogle Scholar
  214. James, W. (1882). Subjective effects of nitrous oxide. Mind, 7.Google Scholar
  215. James, W. (1890). The hidden self. Scribners, 361–373.Google Scholar
  216. James, W. (1904). A world of pure experience. The Journal of Philosophy, Psychology and Scientific Methods, 1(20), 533.CrossRefGoogle Scholar
  217. James, W. (1985). The varieties of religious experience: a study in human nature. London: Penguin Classics. (Originally published in 1902).Google Scholar
  218. Jay, M. (2019). Mescaline: a global history of the first psychedelic. Yale University Press.Google Scholar
  219. Jensen, H. (1932). Chemical studies on toad poisons, IV, bufagin and cinobufagin. Science, 75(1932), 53–54.CrossRefPubMedGoogle Scholar
  220. Jimenez de Asúa, L. (1951). Nullum crimen, nulla poena sine lege. Zeitschrift Für Die Gesamte Strafrechtswissenschaft, 63(1).Google Scholar
  221. Johansen, P.-Ø., & Krebs, T. S. (2015). Psychedelics not linked to mental health problems or suicidal behavior: a population study. Journal of Psychopharmacology, 29(3), 270–279.CrossRefPubMedGoogle Scholar
  222. Johnson, M., Richards, W., & Griffiths, R. (2008). Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology, 22(6), 603–620.CrossRefPubMedGoogle Scholar
  223. Jones, P. N. (2007). The Native American church, Peyote, and health: expanding consciousness for healing purposes. Contemporary Justice Review, 10(4), 411–425.CrossRefGoogle Scholar
  224. Josipovic, Z. (2010). Duality and nonduality in meditation research. Consciousness and Cognition, 19(4), 1119–1121.CrossRefPubMedGoogle Scholar
  225. Josipovic, Z. (2014). Neural correlates of nondual awareness in meditation. Annals of the New York Academy of Sciences, 1307(1), 9–18.CrossRefPubMedGoogle Scholar
  226. Jung, C. G. (1969). Aion: researches into the phenomenology of the self, collected works of C. G. Jung (Volume 9). Princeton, N.J.: Princeton University Press.Google Scholar
  227. Kaczynski, T. J. (1995). Industrial society and its future. Jolly Roger Press.Google Scholar
  228. Kahneman, D., Knetsch, J. L., & Thaler, R. H. (1991). Anomalies: the endowment effect, loss aversion, and status quo bias. Journal of Economic Perspectives, 5(1), 193–206.CrossRefGoogle Scholar
  229. Kandel, R. E. (2015). The age of insight: the quest to understand the unconscious in art, mind and brain. The effects of brief mindfulness intervention on acute pain experience: an examination of individual difference (Vol. 1).Google Scholar
  230. Kapoor, H., & Khan, A. (2017). Deceptively yours: valence-based creativity and deception. Thinking Skills and Creativity, 23, 199–206.CrossRefGoogle Scholar
  231. Kapoor, P., Chugh, Y., Kapoor, A., & Sinha, U. S. (2008). Torture, terrorist and truth serum, 10, 64–70.Google Scholar
  232. Kauder, E. (1899). Über Alkaloide aus Anhalonium Lewinii. Archiv Der Pharmazie, 237(3), 190–198.CrossRefGoogle Scholar
  233. Kaufman, J. C. (2012). Counting the muses: development of the Kaufman Domains of Creativity Scale (K-DOCS). Psychology of Aesthetics, Creativity, and the Arts, 6(4), 298–308.CrossRefGoogle Scholar
  234. Kaufman, S. B., Quilty, L. C., Grazioplene, R. G., Hirsh, J. B., Gray, J. R., Peterson, J. B., & Deyoung, C. G. (2016). Openness to experience and intellect differentially predict creative achievement in the arts and sciences. Journal of Personality, 84(2), 248–258.CrossRefPubMedGoogle Scholar
  235. Kavan, H. (2004). Glossolalia and altered states of consciousness in two New Zealand religious movements. Journal of Contemporary Religion, 19(2), 171–184.CrossRefGoogle Scholar
  236. Kaye, J. (2010). Obama interrogation official linked to U.S. mind control research. Retrieved from: http://pubrecord.org/torture/7730/obama-inter.
  237. Keane, H. (2008). Pleasure and discipline in the uses of Ritalin. International Journal of Drug Policy, 19(5), 401–409.CrossRefPubMedGoogle Scholar
  238. Kekulé, A. (1866). Untersuchungen über aromatische Verbindungen. Annalen Der Chemie Und Pharmacie, 137(2), 129–196.CrossRefGoogle Scholar
  239. Kekulé, A. (1890). Benzolfest: Rede. Berichte Der Deutschen Chemischen Gesellschaft, 23(1), 1302–1311.Google Scholar
  240. Keller, L. M. (2004). Is truth serum torture? SSRN Electronic Journal.Google Scholar
  241. Key, D., & Kerr, M. (2011). The Ouroboros (part I): towards an ontology of connectedness in ecopsychology research. European Journal of Ecopsychology.Google Scholar
  242. Kim, Y., Teylan, M. A., Baron, M., Sands, A., Nairn, A. C., & Greengard, P. (2009). Methylphenidate-induced dendritic spine formation and DeltaFosB expression in nucleus accumbens. Proceedings of the National Academy of Sciences of the United States of America, 106(8), 2915–2920.CrossRefPubMedPubMedCentralGoogle Scholar
  243. King, L. A. (2013). Legal classification of novel psychoactive substances: an international comparison. In Novel Psychoactive Substances: Classification, Pharmacology and Toxicology.Google Scholar
  244. Kischka, U., Kammer, T. H., Maier, S., Weisbrod, M., Thimm, M., & Spitzer, M. (1996). Dopaminergic modulation of semantic network activation. Neuropsychologia, 34(11), 1107–1113.CrossRefPubMedGoogle Scholar
  245. Koçak, O. M., Kale, E., & Çiçek, M. (2012). Default mode network connectivity differences in obsessive-compulsive disorder. Activitas Nervosa Superior, 54(3–4), 118–124.CrossRefGoogle Scholar
  246. Konar, A. K. (2012). Defamiliarizing the demographic doomsday diagram. Mother Pelican, 8(2).Google Scholar
  247. Korotayev, A., & Malkov, A. (2016). A compact mathematical model of the world system economic and demographic growth, 1 CE – 1973 CE. International Journal of Mathematical Models and Methods in Applied Sciences, 10.Google Scholar
  248. Kraehenmann, R., Preller, K. H., Scheidegger, M., Pokorny, T., Bosch, O. G., Seifritz, E., & Vollenweider, F. X. (2015). Psilocybin-induced decrease in amygdala reactivity correlates with enhanced positive mood in healthy volunteers. Biological Psychiatry, 78(8), 572–581.CrossRefPubMedGoogle Scholar
  249. Krebs, T. S., & Johansen, P.-Ø. (2013). Psychedelics and mental health: a population study. PLoS One, 8(8), e63972.CrossRefPubMedPubMedCentralGoogle Scholar
  250. Krebs-Thomson, K., Ruiz, E. M., Masten, V., Buell, M., & Geyer, M. A. (2006). The roles of 5-HT1A and 5-HT2 receptors in the effects of 5-MeO-DMT on locomotor activity and prepulse inhibition in rats. Psychopharmacology, 189(3), 319–329.CrossRefPubMedGoogle Scholar
  251. Krishnamurti, J. (1969). Freedom from the known. Rider.Google Scholar
  252. Kuhn, T. (1970). The structure of scientific revolutions. University of Chicago Press, University of Chicago. Google Scholar
  253. Kuhn, H. G., Biebl, M., Wilhelm, D., Li, M., Friedlander, R. M., & Winkler, J. (2005). Increased generation of granule cells in adult Bcl-2-overexpressing mice: a role for cell death during continued hippocampal neurogenesis. European Journal of Neuroscience.Google Scholar
  254. L’Etang, J. (1999). The father of spin: Edward L. Bernays and the birth of public relations. Public Relations Review, 25(1), 123–124.CrossRefGoogle Scholar
  255. Lachenmeier, D. W., & Rehm, J. (2015). Comparative risk assessment of alcohol, tobacco, cannabis and other illicit drugs using the margin of exposure approach. Scientific Reports, 5(1), 8126.CrossRefPubMedPubMedCentralGoogle Scholar
  256. Lakoff, G. (1986). A figure of thought. Metaphor and Symbolic Activity, 1(3), 215–225.CrossRefGoogle Scholar
  257. Lakoff, G., & Johnson, M. (1981). Metaphors we live by. University of Chicago Press.Google Scholar
  258. Lakoff, G., & Núñez, R. E. (2000). Where mathematics comes from: how the embodied mind brings mathematics into being. Basic Books.Google Scholar
  259. Lamb, T. D. (2013). Evolution of phototransduction, vertebrate photoreceptors and retina. Progress in Retinal and Eye Research, 36, 52–119.CrossRefPubMedGoogle Scholar
  260. Langmead, C. J., & Christopoulos, A. (2013). Supra-physiological efficacy at GPCRs: superstition or super agonists? British Journal of Pharmacology, 169(2), 353–356.CrossRefPubMedPubMedCentralGoogle Scholar
  261. Leary, M. R., Diebels, K. J., Davisson, E. K., Jongman-Sereno, K. P., Isherwood, J. C., Raimi, K. T., … Hoyle, R. H. (2017). Cognitive and interpersonal features of intellectual humility. Personality and Social Psychology Bulletin.Google Scholar
  262. Lebedev, A. V., Kaelen, M., Lövdén, M., Nilsson, J., Feilding, A., Nutt, D. J., & Carhart-Harris, R. L. (2016). LSD-induced entropic brain activity predicts subsequent personality change. Human Brain Mapping, 37(9), 3203–3213.CrossRefPubMedGoogle Scholar
  263. Lee, C. S., Huggins, A. C., & Therriault, D. J. (2014). A measure of creativity or intelligence? Examining internal and external structure validity evidence of the Remote Associates Test. Psychology of Aesthetics, Creativity, and the Arts, 8(4), 446–460.CrossRefGoogle Scholar
  264. Lerner, M. J. (1997). What does the belief in a just world protect us from: the dread of death or the fear of understanding suffering? Psychological Inquiry, 8(1), 29–32.CrossRefGoogle Scholar
  265. Levine, J. (1983). Materialism and qualia: the explanatory gap. Pacific Philosophical Quarterly.Google Scholar
  266. Lewin, L. (1894). Über Anhalonium Lewinii und andere Cacteen. Archiv Für Experimentelle Pathologie Und Pharmakologie.Google Scholar
  267. Lewis, S. L., & Maslin, M. A. (2015). Defining the Anthropocene. Nature, 519(7542), 171–180.CrossRefPubMedGoogle Scholar
  268. Lima da Cruz, R. V., Moulin, T. C., Petiz, L. L., & Leão, R. N. (2018). A single dose of 5-MeO-DMT stimulates cell proliferation, neuronal survivability, morphological and functional changes in adult mice ventral dentate gyrus. Frontiers in Molecular Neuroscience, 11, 312.CrossRefPubMedPubMedCentralGoogle Scholar
  269. Lin, P., Bekey, G., & Abney, K. (2008). Autonomous military robotics: risk, ethics, and design. California Polytechnic State University.Google Scholar
  270. Luerssen, A., Gyurak, A., Ayduk, O., Wendelken, C., & Bunge, S. A. (2015). Delay of gratification in childhood linked to cortical interactions with the nucleus accumbens. Social Cognitive and Affective Neuroscience, 10(12), 1769–1776. https://doi.org/10.1093/scan/nsv068.
  271. Lyons, T., & Carhart-Harris, R. L. (2018). Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression. Journal of Psychopharmacology, 32(7), 811–819.CrossRefPubMedGoogle Scholar
  272. MacLean, K. A., Johnson, M. W., & Griffiths, R. R. (2011). Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. Journal of Psychopharmacology, 25(11), 1453–1461.CrossRefPubMedGoogle Scholar
  273. Majić, T., Schmidt, T. T., & Gallinat, J. (2015). Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences? Journal of Psychopharmacology, 29(3), 241–253.CrossRefPubMedGoogle Scholar
  274. Mano, H., & Fukada, Y. (2006). A median third eye: pineal gland retraces evolution of vertebrate photoreceptive organs. Photochemistry and Photobiology.Google Scholar
  275. Markoff, J. (2005). What the dormouse said: how the sixties counterculture shaped the personal computer industry. New York: Viking.Google Scholar
  276. Marques, J. (2012). Consciousness at work: a review of some important values, discussed from a Buddhist perspective. Journal of Business Ethics, 105(1), 27–40.CrossRefGoogle Scholar
  277. Martin, D. A., & Nichols, C. D. (2018). The effects of hallucinogens on gene expression. In Current Topics in Behavioral Neurosciences (Vol. 36, pp. 137–158).Google Scholar
  278. Martorana, F., Gaglio, D., Bianco, M. R., Aprea, F., Virtuoso, A., Bonanomi, M., … Colangelo, A. M. (2018). Differentiation by nerve growth factor (NGF) involves mechanisms of crosstalk between energy homeostasis and mitochondrial remodeling. Cell Death & Disease, 9(3), 391.Google Scholar
  279. Maruani, A., Dumas, G., Beggiato, A., Traut, N., Peyre, H., Cohen-Freoua, A., … Delorme, R. (2019). Morning plasma melatonin differences in autism: beyond the impact of pineal gland volume. Frontiers in Psychiatry, 10.Google Scholar
  280. Maslow, A. (1962). The psychology of science. Gateway Editions.Google Scholar
  281. Maslow, A. (1968). Toward a psychology of being. 2nd ed Google Scholar
  282. Mausfeld, R. (2017). Warum schweigen die Lämmer? Wie Elitendemokratie und Neoliberalismus unsere Gesellschaft und unsere Lebensgrundlagen zerstören. Westend Verlag.Google Scholar
  283. Mausfeld, R. (2019). Angst und Macht: Herrschaftstechniken der Angsterzeugung in kapitalistischen Demokratien. Westend Verlag.Google Scholar
  284. May, L. T., Leach, K., Sexton, P. M., & Christopoulos, A. (2007). Allosteric modulation of G protein–coupled receptors. Annual Review of Pharmacology and Toxicology, 47(1), 1–51.CrossRefPubMedGoogle Scholar
  285. McClintick, J. N., Xuei, X., Tischfield, J. A., Goate, A., Foroud, T., Wetherill, L., … Edenberg, H. J. (2013). Stress–response pathways are altered in the hippocampus of chronic alcoholics. Alcohol, 47(7), 505–515.Google Scholar
  286. McCoy, A. W. (2006). A question of torture : CIA interrogation, from the Cold War to the War on Terror. Metropolitan Books/Henry Holt and Co.Google Scholar
  287. McCoy, A. W. (2007). Science in Dachau’s shadow: HEBB, Beecher, and the development of CIA psychological torture and modern medical ethics. Journal of the History of the Behavioral Sciences, 43(4), 401–417.CrossRefPubMedGoogle Scholar
  288. McCrae, R. R. (1994). Openness to experience: expanding the boundaries of factor V. European Journal of Personality.Google Scholar
  289. McDougall, W. (1930). The hormic psychology. In Psychologies of 1930. (pp. 3–36). Worcester: Clark University Press.Google Scholar
  290. McKenna, T. (1992). Food of the gods: the search for the original tree of knowledge: a radical history of plants, drugs and human evolution. Rider.Google Scholar
  291. Melley, T. (2017). War on terror. In American Literature in Transition, 2000–2010 (pp. 275–288). Cambridge University Press.Google Scholar
  292. Metzner, R. (2015). Allies for awakening: guidelines for productive and safe experiences with entheogens. Berkeley, CA: Green Earth Foundation & Regent Press.Google Scholar
  293. Millière, R. (2017). Looking for the self: phenomenology, neurophysiology and philosophical significance of drug-induced ego dissolution. Frontiers in Human Neuroscience, 11.Google Scholar
  294. Minkov, M., & Hofstede, G. (2012). Hofstede’s fifth dimension. Journal of Cross-Cultural Psychology, 43(1), 3–14.CrossRefGoogle Scholar
  295. Mischel, W., Ebbesen, E. B., & Raskoff Zeiss, A. (1972). Cognitive and attentional mechanisms in delay of gratification. Journal of Personality and Social Psychology, 21(2), 204–218.CrossRefPubMedGoogle Scholar
  296. Misra, B., & Sudarshan, E. C. G. (1977). The Zeno’s paradox in quantum theory. Journal of Mathematical Physics, 18(4), 756–763.CrossRefGoogle Scholar
  297. Monterosso, J., Piray, P., & Luo, S. (2012). Neuroeconomics and the study of addiction. Biological Psychiatry, 72(2), 107–112.CrossRefPubMedGoogle Scholar
  298. Moon, J. S., Kuza, C. M., & Desai, M. S. (2018). William James, nitrous oxide, and the anaesthetic revelation. Journal of Anesthesia History, 4(1), 1–6.CrossRefPubMedGoogle Scholar
  299. Moore, L. D., & Elkavich, A. (2008). Who’s using and who’s doing time: incarceration, the war on drugs, and public health. American Journal of Public Health.Google Scholar
  300. Moore, D. W., Bhadelia, R. A., Billings, R. L., Fulwiler, C., Heilman, K. M., Rood, K. M. J., & Gansler, D. A. (2009). Hemispheric connectivity and the visual-spatial divergent-thinking component of creativity. Brain and Cognition, 70(3), 267–272.CrossRefPubMedGoogle Scholar
  301. Moreno, J. D. (2012). Mind wars: brain science and the military in the twenty-first century. Bellevue Literary Press.Google Scholar
  302. Mueller, I. (2005). Mathematics and the divine in Plato. In Mathematics and the Divine (pp. 99–121).Google Scholar
  303. Müller, K., Püschel, K., & Iwersen-Bergmann, S. (2013a). Suizid unter Psilocin-Einfluss. Archiv Fur Kriminologie, 231, 193–198.PubMedGoogle Scholar
  304. Müller, U. J., Voges, J., Steiner, J., Galazky, I., Heinze, H. J., Möller, M., … Kuhn, J. (2013b). Deep brain stimulation of the nucleus accumbens for the treatment of addiction. Annals of the New York Academy of Sciences.Google Scholar
  305. Müller, B. C. N., Gerasimova, A., & Ritter, S. M. (2016). Concentrative meditation influences creativity by increasing cognitive flexibility. Psychology of Aesthetics, Creativity, and the Arts.Google Scholar
  306. Mullis, K. (2000). Dancing naked in the mind field. New York: Vintage Books.Google Scholar
  307. Mumford, L. (1967). The myth of the machine. Harcourt, Brace & World.Google Scholar
  308. Muraven, M., & Baumeister, R. F. (2000). Self-regulation and depletion of limited resources: does self-control resemble a muscle? Psychological Bulletin.Google Scholar
  309. Muthukumaraswamy, S. D., Carhart-Harris, R. L., Moran, R. J., Brookes, M. J., Williams, T. M., Errtizoe, D., … Nutt, D. J. (2013). Broadband cortical desynchronization underlies the human psychedelic state. Journal of Neuroscience, 33(38), 15171–15183.Google Scholar
  310. Nagai, F., Nonaka, R., & Satoh Hisashi Kamimura, K. (2007). The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain. European Journal of Pharmacology, 559(2–3), 132–137.CrossRefPubMedGoogle Scholar
  311. Nagel, T. (1974). What is it like to be a bat? The Philosophical Review, 83(4), 435.CrossRefGoogle Scholar
  312. Namazi, H. R. (2017). The complexity based analysis of the correlation between spider’s brain signal and web. ARC Journal of Neuroscience, 2, 44.Google Scholar
  313. Nelson, T. (1975). Computer lib/dream machines. South Bend: Nelson.Google Scholar
  314. Nichols, D. E. (2004). Hallucinogens. Pharmacology and Therapeutics.Google Scholar
  315. Nichols, D. E. (2018a). Dark classics in chemical neuroscience: lysergic acid diethylamide (LSD). ACS Chemical Neuroscience.Google Scholar
  316. Nichols, D. E. (2018b). N,N-dimethyltryptamine and the pineal gland: separating fact from myth. Journal of Psychopharmacology, 32(1), 30–36.CrossRefPubMedGoogle Scholar
  317. Nour, M. M., Evans, L., Nutt, D., & Carhart-Harris, R. L. (2016). Ego-dissolution and psychedelics: validation of the Ego-Dissolution Inventory (EDI). Frontiers in Human Neuroscience, 10, 269.CrossRefPubMedPubMedCentralGoogle Scholar
  318. Nour, M. M., Evans, L., & Carhart-Harris, R. L. (2017). Psychedelics, personality and political perspectives. Journal of Psychoactive Drugs, 49(3), 182–191.CrossRefPubMedGoogle Scholar
  319. Nunn, N., & Qian, N. (2010). The Columbian exchange: a history of disease, food, and ideas. Journal of Economic Perspectives, 24(2), 163–188.CrossRefGoogle Scholar
  320. O’Mara, S. (2009). Torturing the brain. Trends in Cognitive Sciences, 13(12), 497–500.CrossRefPubMedGoogle Scholar
  321. Olds, J., & Milner, P. (1954). Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. Journal of Comparative and Physiological Psychology, 47(6), 419–427.CrossRefPubMedGoogle Scholar
  322. Osmond, H. (1957). A review of the clinical effects of psychotomimetic agents. Annals of the New York Academy of Sciences, 66(3), 418–434.CrossRefPubMedGoogle Scholar
  323. Ostafin, B. D., & Kassman, K. T. (2012). Stepping out of history: mindfulness improves insight problem solving. Consciousness and Cognition.Google Scholar
  324. Ott, J. (2001). Pharmepéna-psychonautics: human intranasal, sublingual and oral pharmacology of 5-methoxy-N, N-dimethyl-tryptamine. Journal of Psychoactive Drugs.Google Scholar
  325. Otterman, M. (2017). American torture. Pluto Press.Google Scholar
  326. Pachter, I. J., Zacharias, D. E., & Ribeirol, O. (1959). Indole alkaloids of Acer saccharinum (the silver maple), Dictyoloma incanescens, Piptadenia colubrina, and Mimosa hostilis. Journal of Organic Chemistry.Google Scholar
  327. Panossian, A., Wikman, G., Kaur, P., & Asea, A. (2012). Adaptogens stimulate neuropeptide Y and Hsp72 expression and release in neuroglia cells. Frontiers in Neuroscience, 6.Google Scholar
  328. Parkinson, T. D., Kornelsen, J., & Smith, S. D. (2019). Trait mindfulness and functional connectivity in cognitive and attentional resting state networks. Frontiers in Human Neuroscience.Google Scholar
  329. Passamonti, L., Terracciano, A., Riccelli, R., Donzuso, G., Cerasa, A., Vaccaro, M. G., … Quattrone, A. (2014). Increased functional connectivity within mesocortical networks in open people. NeuroImage.Google Scholar
  330. Peet, M. (1979). Transcendental meditation. BMJ, 1(6157), 201–201.CrossRefGoogle Scholar
  331. Peres, A. (1980). Zeno paradox in quantum theory. American Journal of Physics, 48(11), 931–932.CrossRefGoogle Scholar
  332. Petty, R. E., & Cacioppo, J. T. (1986). The elaboration likelihood model of persuasion. In Advances in Experimental Social Psychology (pp. 123–205).Google Scholar
  333. Philipchalk, R., & Mueller, D. (2000). Glossolalia and temperature change in the right and left cerebral hemispheres. International Journal of Phytoremediation.Google Scholar
  334. Phillips, J., Frances, A., Cerullo, M. A., Chardavoyne, J., Decker, H. S., First, M. B., … Zachar, P. (2012a). The six most essential questions in psychiatric diagnosis: a pluralogue. Part 4: general conclusion. Philosophy, Ethics, and Humanities in Medicine.Google Scholar
  335. Phillips, J., Frances, A., Cerullo, M. A., Chardavoyne, J., Decker, H. S., First, M. B., … Zachar, P. (2012b). The six most essential questions in psychiatric diagnosis: a pluralogue part 1: conceptual and definitional issues in psychiatric diagnosis. Philosophy, Ethics, and Humanities in Medicine.Google Scholar
  336. Phillips, J., Frances, A., Cerullo, M. A., Chardavoyne, J., Decker, H. S., First, M. B., … Zachar, P. (2012c). The six most essential questions in psychiatric diagnosis: a pluralogue part 2: issues of conservatism and pragmatism in psychiatric diagnosis. Philosophy, Ethics, and Humanities in Medicine.Google Scholar
  337. Phillips, J., Frances, A., Cerullo, M. A., Chardavoyne, J., Decker, H. S., First, M. B., … Zachar, P. (2012d). The six most essential questions in psychiatric diagnosis: a pluralogue part 3: issues of utility and alternative approaches in psychiatric diagnosis. Philosophy, Ethics, and Humanities in Medicine.Google Scholar
  338. Power, R. A., Steinberg, S., Bjornsdottir, G., Rietveld, C. A., Abdellaoui, A., Nivard, M. M., … Stefansson, K. (2015). Polygenic risk scores for schizophrenia and bipolar disorder predict creativity. Nature Neuroscience, 18(7), 953–955.Google Scholar
  339. Prabhu, V., Sutton, C., & Sauser, W. (2008). Creativity and certain personality traits: understanding the mediating effect of intrinsic motivation. Creativity Research Journal.Google Scholar
  340. Price, D. H. (2007). Buying a piece of anthropology part 1: human ecology and unwitting anthropological research for the CIA. Anthropology Today, 23(3), 8–13.CrossRefGoogle Scholar
  341. Provencio, I., Rodriguez, I. R., Jiang, G., Hayes, W. P., Moreira, E. F., & Rollag, M. D. (2000). A novel human opsin in the inner retina. The Journal of Neuroscience, 20(2), 600–605.CrossRefPubMedGoogle Scholar
  342. Quine, W. V. & Ullian, J. S. (1978). The web of belief. Social Sciences/Languages.Google Scholar
  343. Ramachandran, V. S., & Hirstein, W. (1999). The science of art: a neurological theory of aesthetic experience. Journal of Consciousness Studies.Google Scholar
  344. Rätsch, C. (1998). Enzyklopädie der psychoaktiven Pflanzen : Botanik, Ethnopharmakologie und Anwendung. Wissenschaftliche Verlagsgesellschaft.Google Scholar
  345. Rauter, T. (2017). Nullum Crimen Sine Lege. In Judicial practice, customary international criminal law and Nullum Crimen Sine Lege (pp. 19–86). Cham: Springer International Publishing.CrossRefGoogle Scholar
  346. Régnier, C., Achaz, G., Lambert, A., Cowie, R. H., Bouchet, P., & Fontaine, B. (2015). Mass extinction in poorly known taxa. Proceedings of the National Academy of Sciences, 112(25), 7761–7766.CrossRefGoogle Scholar
  347. Riga, M. S., Soria, G., Tudela, R., Artigas, F., & Celada, P. (2014). The natural hallucinogen 5-MeO-DMT, component of Ayahuasca, disrupts cortical function in rats: reversal by antipsychotic drugs. The International Journal of Neuropsychopharmacology, 17(08), 1269–1282.CrossRefPubMedGoogle Scholar
  348. Ripple, W. J., Wolf, C., Newsome, T. M., Galetti, M., Alamgir, M., Crist, E., … Laurance, W. F. (2017). World scientists’ warning to humanity: a second notice. BioScience, 67(12), 1026–1028.Google Scholar
  349. Rizzo, P., Tinello, C., Pearlstein, R. A., & Taniuchi, H. (1999). Antibody immunodiversity: a study on the marked specificity difference between two anti-yeast iso-1 cytochrome c monoclonal antibodies whose epitopes are closely related. Journal of Protein Chemistry.Google Scholar
  350. Roberts, T. B. (2006). Psychedelic horizons: Snow White, immune system, multistate mind, enlarging education. Imprint Academic.Google Scholar
  351. Rocke, A. J. (2015). It began with a daydream: the 150th anniversary of the Kekulé benzene structure. Angewandte Chemie (International Ed. in English), 54(1), 46–50.CrossRefGoogle Scholar
  352. Rose, N., & Abi-Rached, J. (2014). Governing through the brain: neuropolitics, neuroscience and subjectivity. The Cambridge Journal of Anthropology, 32(1).Google Scholar
  353. Roseman, L., Sereno, M. I., Leech, R., Kaelen, M., Orban, C., McGonigle, J., … Carhart-Harris, R. L. (2016). LSD alters eyes-closed functional connectivity within the early visual cortex in a retinotopic fashion. Human Brain Mapping, 37(8), 3031–3040.Google Scholar
  354. Roseman, L., Demetriou, L., Wall, M. B., Nutt, D. J., & Carhart-Harris, R. L. (2018). Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression. Neuropharmacology, 142, 263–269.CrossRefPubMedGoogle Scholar
  355. Rossi, C., Angelucci, A., Costantin, L., Braschi, C., Mazzantini, M., Babbini, F., … Caleo, M. (2006). Brain-derived neurotrophic factor (BDNF) is required for the enhancement of hippocampal neurogenesis following environmental enrichment. European Journal of Neuroscience, 24(7), 1850–1856.Google Scholar
  356. Roth, B. L., Baner, K., Westkaemper, R., Siebert, D., Rice, K. C., Steinberg, S., … Rothman, R. B. (2002). Salvinorin A: a potent naturally occurring nonnitrogenous opioid selective agonist. Proceedings of the National Academy of Sciences, 99(18), 11934–11939.Google Scholar
  357. Routledge, C. D., & Arndt, J. (2009). Creative terror management: creativity as a facilitator of cultural exploration after mortality salience. Personality and Social Psychology Bulletin.Google Scholar
  358. Ruck, C. A. P., Bigwood, J., Staples, D., Ott, J., & Wasson, G. (1979). Entheogens. Journal of Psychoactive Drugs, 11(1–2), 145–146.Google Scholar
  359. Rucker, J. J. H. (2015). Psychedelic drugs should be legally reclassified so that researchers can investigate their therapeutic potential. BMJ, 350(may26 20), h2902–h2902.CrossRefPubMedGoogle Scholar
  360. Rudd, M., Vohs, K. D., & Aaker, J. (2012). Awe expands people’s perception of time, alters decision making, and enhances well-being. Psychological Science.Google Scholar
  361. Russell, B. (1952). The impact of science on society. Routledge.Google Scholar
  362. Russell, B. (1981). Mysticism and logic, and other essays. Barnes & Noble Books.Google Scholar
  363. Sanchez-Ramos, J. (2015). The entourage effect of the phytocannabinoids. Annals of Neurology.Google Scholar
  364. Sand, S. (2007). The development of psychological torture: a modern history of coercive interrogation and its effectiveness.Google Scholar
  365. Sapir, E. (1929). The status of linguistics as a science. Language, 5(4), 207.CrossRefGoogle Scholar
  366. Saunders, R. (2012). Towards autonomous creative systems: a computational approach. Cognitive Computation, 4(3), 216–225.CrossRefGoogle Scholar
  367. Saville, B. K., Gisbert, A., Kopp, J., & Telesco, C. (2010). Internet addiction and delay discounting in college students. The Psychological Record, 60(2), 273–286.CrossRefGoogle Scholar
  368. Schartner, M. M., Carhart-Harris, R. L., Barrett, A. B., Seth, A. K., & Muthukumaraswamy, S. D. (2017). Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin. Scientific Reports, 7(April), 46421.CrossRefPubMedPubMedCentralGoogle Scholar
  369. Schläpfer, T., & Kayser, S. (2014). Tiefe Hirnstimulation bei therapieresistenter Depression. Klinische Neurophysiologie, 45(02), 113–117.CrossRefGoogle Scholar
  370. Schlosshauer, M., Kofler, J., & Zeilinger, A. (2013). A snapshot of foundational attitudes toward quantum mechanics. Studies in History and Philosophy of Science Part B – Studies in History and Philosophy of Modern Physics, 44(3), 222–230.CrossRefGoogle Scholar
  371. Schoch, R. (1994). A conversation with Kerry Mullis. California Monthly, 105(1), 20.Google Scholar
  372. Schopenhauer, A. (1851). Parerga and paralipomena. In 2000. Trans. E.F.J. Payne, New York, Oxford University Press 1974. Reissued Norfolk, Biddles Ltd., Ed.Google Scholar
  373. Schredl, M., Atanasova, D., Hörmann, K., Maurer, J. T., Hummel, T., & Stuck, B. A. (2009). Information processing during sleep: the effect of olfactory stimuli on dream content and dream emotions. Journal of Sleep Research.Google Scholar
  374. Schwartz, T. W., & Holst, B. (2007). Allosteric enhancers, allosteric agonists and ago-allosteric modulators: where do they bind and how do they act? Trends in Pharmacological Sciences.Google Scholar
  375. Scott, W. A. (2006). Cognitive complexity and cognitive flexibility. Sociometry.Google Scholar
  376. Sessa, B. (2012). Shaping the renaissance of psychedelic research. The Lancet, 380(9838), 200–201.CrossRefGoogle Scholar
  377. Sheldrake, R., McKenna, T. K., Abraham, R., & Abraham, R. (2001). Chaos, creativity, and cosmic consciousness. Park Street Press.Google Scholar
  378. Shen, H.-W., Jiang, X.-L., Winter, J. C., & Yu, A.-M. (2010a). Psychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions. Current Drug Metabolism, 11(8), 659–666.CrossRefPubMedPubMedCentralGoogle Scholar
  379. Shen, H. W., Wu, C., Jiang, X. L., & Yu, A. M. (2010b). Effects of monoamine oxidase inhibitor and cytochrome P450 2D6 status on 5-methoxy-N,N-dimethyltryptamine metabolism and pharmacokinetics. Biochemical Pharmacology.Google Scholar
  380. Shen, W., Liu, C., Zhang, X., Zhao, X., Zhang, J., Yuan, Y., & Chen, Y. (2013). Right hemispheric dominance of creative insight: an event-related potential study. Creativity Research Journal, 25(1), 48–58.CrossRefGoogle Scholar
  381. Shen, X., Finn, E. S., Scheinost, D., Rosenberg, M. D., Chun, M. M., Papademetris, X., & Constable, R. T. (2017). Using connectome-based predictive modeling to predict individual behavior from brain connectivity. Nature Protocols, 12(3), 506–518.CrossRefPubMedPubMedCentralGoogle Scholar
  382. Shulgin, A. T., & Carter, M. F. (1980). N,N-diisopropyltryptamine (DIPT) and 5-methoxy-N,N-diisoppropyltryptamine (5-MeO-DIPT). Two orally active tryptamine analogs with CNS activity. Communications in Psychopharmacology.Google Scholar
  383. Shulgin, A. A., & Shulgin, A. A. (1997). TIHKAL. The continuation. Transform Press.Google Scholar
  384. Shultes, E. R. (1976). A golden guide: hallucinogenic plants. New York.Google Scholar
  385. Siegel, D. J. (2010). Mindsight: the new science of personal transformation. California: Bantam Books.Google Scholar
  386. Silvia, P. J., Nusbaum, E. C., Berg, C., Martin, C., & O’Connor, A. (2009). Openness to experience, plasticity, and creativity: exploring lower-order, high-order, and interactive effects. Journal of Research in Personality, 43(6), 1087–1090.CrossRefGoogle Scholar
  387. Singer, P. (1990). Ethics and animals. Behavioral and Brain Sciences, 13(1), 45–48.CrossRefGoogle Scholar
  388. Sivananda, S. R. I. S. (1972). Bhagavad gita. World, 23–24.Google Scholar
  389. Slattery, D. (2015). Xenolinguistics: psychedelics, language, and the evolution of consciousness. Berkeley, California: North Atlantic Books.Google Scholar
  390. Smigielski, L., Scheidegger, M., Kometer, M., & Vollenweider, F. X. (2019). Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects. NeuroImage, 196, 207–215.CrossRefPubMedGoogle Scholar
  391. Smith, G., & Chomsky, N. (1987). On power and ideology: the Managua lectures. Foreign Affairs, 65(5), 1105.Google Scholar
  392. Stanovich, K. E., & West, R. F. (2008). On the relative independence of thinking biases and cognitive ability. Journal of Personality and Social Psychology.Google Scholar
  393. Stanton, S. J., Sinnott-Armstrong, W., & Huettel, S. A. (2017). Neuromarketing: ethical implications of its use and potential misuse. Journal of Business Ethics, 144(4), 799–811.CrossRefGoogle Scholar
  394. Stapp, H. (2001). Quantum theory and the role of mind in nature. Foundations of Physics, 31(10), 1465–1499.CrossRefGoogle Scholar
  395. Stapp, H. (2007). Quantum mechanical theories of consciousness. In The Blackwell companion to consciousness (pp. 300–312).Google Scholar
  396. Steffen, W., Broadgate, W., Deutsch, L., Gaffney, O., & Ludwig, C. (2015). The trajectory of the Anthropocene: the great acceleration. The Anthropocene Review, 2(1), 81–98.CrossRefGoogle Scholar
  397. Steffen, W., Rockström, J., Richardson, K., Lenton, T. M., Folke, C., Liverman, D., … Schellnhuber, H. J. (2018). Trajectories of the Earth system in the Anthropocene. Proceedings of the National Academy of Sciences, 115(33), 8252–8259.Google Scholar
  398. Strassman, R. (2001). DMT: the spirit molecule. Rochester, VT, (March), 7821.Google Scholar
  399. Sugarman, J. (2015). Neoliberalism and psychological ethics. Journal of Theoretical and Philosophical Psychology, 35(2), 103–116.CrossRefGoogle Scholar
  400. Sun, J., Chen, Q., Zhang, Q., Li, Y., Li, H., Wei, D., … Qiu, J. (2016). Training your brain to be more creative: brain functional and structural changes induced by divergent thinking training. Human Brain Mapping, 37(10), 3375–3387.Google Scholar
  401. Sunstein, C. R., & Vermeule, A. (2008). Conspiracy theories. SSRN Electronic Journal.Google Scholar
  402. Sunstein, C. R., & Vermeule, A. (2009). Conspiracy theories: causes and cures*. Journal of Political Philosophy, 17(2), 202–227.CrossRefGoogle Scholar
  403. Szabo, A. (2015). Psychedelics and immunomodulation: novel approaches and therapeutic opportunities. Frontiers in Immunology, 6(JUN).Google Scholar
  404. Tagliazucchi, E., Roseman, L., Kaelen, M., Orban, C., Muthukumaraswamy, S. D., Murphy, K., … Carhart-Harris, R. (2016). Increased global functional connectivity correlates with LSD-induced ego dissolution. Current Biology, 26(8), 1043–1050.Google Scholar
  405. Tanner, R. G. (1970). Δianoia and Plato’s cave. The Classical Quarterly, 20(1), 81–91.CrossRefGoogle Scholar
  406. Tart, C. T. (1972). States of consciousness and state-specific sciences. Science (New York, N.Y.), 176(4040), 1203–1210.CrossRefGoogle Scholar
  407. Tart, C. T. (2008). Altered states of consciousness and the spiritual traditions: the proposal for the creation of state-specific sciences. In Handbook of Indian psychology. (pp. 577–609).Google Scholar
  408. Taylor, T., Raine, K., & Harper, G. M. (1969). Thomas Taylor, the Platonist: selected writings. Princeton University Press.Google Scholar
  409. Teh, L. K., & Bertilsson, L. (2012). Pharmacogenomics of CYP2D6: molecular genetics, interethnic differences and clinical importance. Drug Metabolism and Pharmacokinetics, 27(1), 55–67.CrossRefPubMedGoogle Scholar
  410. Tetlock, P. E., Mellers, B. A., Rohrbaugh, N., & Chen, E. (2014). Forecasting tournaments. Current Directions in Psychological Science, 23(4), 290–295.CrossRefGoogle Scholar
  411. Tomasi, D., & Volkow, N. D. (2010). Functional connectivity density mapping. Proceedings of the National Academy of Sciences, 107(21), 9885–9890.CrossRefGoogle Scholar
  412. Torres, C. M., & Repke, D. B. (2006). Anadenanthera: visionary plant of ancient South America. Haworth Herbal Press.Google Scholar
  413. Torres, C. M., Repke, D. B., Chan, K., Mckenna, D., Llagostera, A., & Schultes, R. E. (1991). Snuff powders from pre-Hispanic San Pedro de Atacama: chemical and contextual analysis. Current Anthropology, 32(5), 640–649.CrossRefGoogle Scholar
  414. Tosini, G. (1997). The pineal complex of reptiles: physiological and behavioral roles. Ethology Ecology & Evolution, 9(4), 313–333.CrossRefGoogle Scholar
  415. Trerotola, M., Relli, V., Simeone, P., & Alberti, S. (2015). Epigenetic inheritance and the missing heritability. Human Genomics.Google Scholar
  416. Troxler, F., Seemann, F., & Hofmann, A. (1959). Abwandlungsprodukte von Psilocybin und Psilocin. 2. Mitteilung Über synthetische Indolverbindungen. Helvetica Chimica Acta.Google Scholar
  417. Tupper, K. W. (2002). Entheogens and existential intelligence: the use of plant teachers as cognitive tools. Canadian Journal of Education / Revue Canadienne de l’éducation, 27(4), 499.CrossRefGoogle Scholar
  418. Twarog, B. M. (1988). Serotonin: history of a discovery. Comparative Biochemistry and Physiology Part C: Comparative Pharmacology, 91(1), 21–24.CrossRefGoogle Scholar
  419. Uthaug, M. V., Lancelotta, R., van Oorsouw, K., Kuypers, K. P. C., Mason, N., Rak, J., … Ramaekers, J. G. (2019). A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psyc. Psychopharmacology.Google Scholar
  420. Vaadia, E. (2009). Grand challenges of brain computer interfaces in the years to come. Frontiers in Neuroscience, 3(2), 151–154.CrossRefPubMedPubMedCentralGoogle Scholar
  421. van den Bos, W., & McClure, S. M. (2013). Towards a general model of temporal discounting. Journal of the Experimental Analysis of Behavior, 99(1), 58–73.CrossRefPubMedGoogle Scholar
  422. Vartanian, O. (2013). Fostering creativity: insights from neuroscience. In J. Vartanian, O. Bristol, & A. Kaufman (Eds.), Neuroscience of creativity (pp. 257–271). Cambridge, MA: MIT Press.CrossRefGoogle Scholar
  423. Venn, J. (1880). On the diagrammatic and mechanical representation of propositions and reasonings. Philosophical Magazine Series 5, 59(10), 1–18.Google Scholar
  424. Vitali, S., Glattfelder, J. B., & Battiston, S. (2011). The network of global corporate control. PLoS One.Google Scholar
  425. von Förster, H. (2003). Understanding understanding: essays on cybernetics and cognition. Springer.Google Scholar
  426. von Förster, H., Mora, P. M., & Amiot, L. W. (1960). Doomsday: Friday, 13 November, A.D. 2026. Science, 132(3436), 1291–1295.CrossRefGoogle Scholar
  427. Von Neumann, J. (1955). Mathematical foundations of quantum mechanics. American Mathematical Monthly (Vol. 72).Google Scholar
  428. Walczyk, J. J., & Griffith-Ross, D. A. (2008). Commentary on the functional creativity model: its application to understanding innovative deception. Creativity Research Journal, 20(2), 130–133.CrossRefGoogle Scholar
  429. Walczyk, J. J., Runco, M. A., Tripp, S. M., & Smith, C. E. (2008). The creativity of lying: divergent thinking and ideational correlates of the resolution of social dilemmas. Creativity Research Journal, 20(3), 328–342.CrossRefGoogle Scholar
  430. Wallach, J. V. (2009). Endogenous hallucinogens as ligands of the trace amine receptors: a possible role in sensory perception. Medical Hypotheses, 72(1), 91–94.CrossRefPubMedGoogle Scholar
  431. Wals, A. E. J., & Jickling, B. (2002). “Sustainability” in higher education: from doublethink and newspeak to critical thinking and meaningful learning. Higher Education Policy, 15(2), 121–131.CrossRefGoogle Scholar
  432. Walsh, C. (2016). Psychedelics and cognitive liberty: reimagining drug policy through the prism of human rights. International Journal of Drug Policy, 29, 80–87.CrossRefPubMedGoogle Scholar
  433. Wang, C., Brunton, E., Haghgooie, S., Cassells, K., Lowery, A., & Rajan, R. (2013). Characteristics of electrode impedance and stimulation efficacy of a chronic cortical implant using novel annulus electrodes in rat motor cortex. Journal of Neural Engineering.Google Scholar
  434. Wasson, G. R., Hofmann, A., & Ruck, C. A. P. (1979). The road to Eleusis: unveiling the secret of the mysteries. The Classical World, 73, 1–28.CrossRefGoogle Scholar
  435. Watson, D. (2003). To dream, perchance to remember: individual differences in dream recall. Personality and Individual Differences.Google Scholar
  436. Weinberger, S. (2011). Spies to use Twitter as crystal ball. Nature.Google Scholar
  437. Weitemier, A. Z., & Ryabinin, A. E. (2003). Alcohol-induced memory impairment in trace fear conditioning: a hippocampus-specific effect. Hippocampus, 13(3), 305–315.CrossRefPubMedGoogle Scholar
  438. Williams, A. D., & Grisham, J. R. (2012). Impulsivity, emotion regulation, and mindful attentional focus in compulsive buying. Cognitive Therapy and Research.Google Scholar
  439. Winkelman, M. (2004). Shamanism as the original neurotheology. Zygon, 39(1), 193–217.CrossRefGoogle Scholar
  440. Winkelman, M. (2015). Psychedelics as medicines for substance abuse rehabilitation: evaluating treatments with LSD, peyote, ibogaine and ayahuasca. Current Drug Abuse Reviews, 7(2), 101–116.CrossRefGoogle Scholar
  441. Winter, A. (2011). Manchurian candidates: forensic hypnosis in the Cold War. Grey Room, 45, 106–127.CrossRefGoogle Scholar
  442. Winter, J., Filipink, R., Timineri, D., Helsley, S., & Rabin, R. (2000). The paradox of 5-methoxy-N,N-dimethyltryptamine. Pharmacology Biochemistry and Behavior, 65(1), 75–82.CrossRefGoogle Scholar
  443. Wiseman, H. (2015). Quantum physics: death by experiment for local realism. Nature, 526(7575), 649–650.CrossRefPubMedGoogle Scholar
  444. Witt, P. N. (1951). d-Lysergsäure-diäthylamid (LSD 25) im Spinnentest. Experientia, 7(8), 310–311.CrossRefPubMedGoogle Scholar
  445. Wolkowitz, O. M., Mellon, S. H., Epel, E. S., Lin, J., Dhabhar, F. S., Su, Y., … Blackburn, E. H. (2011). Leukocyte telomere length in major depression: correlations with chronicity, inflammation and oxidative stress—preliminary findings. PLoS One, 6(3), e17837.Google Scholar
  446. Wolman, B. B. (1981). Hormic and holistic theories. In Contemporary theories and systems in psychology (pp. 180–196). Boston, MA: Springer US.CrossRefGoogle Scholar
  447. Worm, B., Barbier, E. B., Beaumont, N., Duffy, J. E., Folke, C., Halpern, B. S., … Watson, R. (2006). Impacts of biodiversity loss on ocean ecosystem services. Science, 314(5800), 787–790.Google Scholar
  448. Wright, I. A., & Ortiz, F. (1941). Contrapunteo Cubano del Tabaco y el Azucar. The Hispanic American Historical Review, 21(3), 459.CrossRefGoogle Scholar
  449. Wu, J. (1999). Serotonin and learned helplessness: a regional study of 5-HT1A, 5-HT2A receptors and the serotonin transport site in rat brain. Journal of Psychiatric Research, 33(1), 17–22.CrossRefPubMedGoogle Scholar
  450. Young, G. (2008). Capgras delusion: an interactionist model. Consciousness and Cognition.Google Scholar
  451. Yu, K., Liu, C., Yu, T., Wang, X., Xu, C., Ni, D., & Li, Y. (2018). Out-of-body experience in the anterior insular cortex during the intracranial electrodes stimulation in an epileptic child. Journal of Clinical Neuroscience, 54, 122–125.CrossRefPubMedGoogle Scholar
  452. Zakharov, A. V., Khivintseva, E. V., Pyatin, V. F., Sergeeva, M. S., & Antipov, O. I. (2019). Melatonin—known and novel areas of clinical application. Neuroscience and Behavioral Physiology.Google Scholar
  453. Zeese, B. K., & Flowers, M. (2014). Lifting the veil of mirage democracy in the United States. Truthout, (February 2013), 1–13.Google Scholar
  454. Zhang, J., Rane, G., Dai, X., Shanmugam, M. K., Arfuso, F., Samy, R. P., … Sethi, G. (2016). Ageing and the telomere connection: an intimate relationship with inflammation. Ageing Research Reviews, 25, 55–69.Google Scholar
  455. Zhuk, O., Jasicka-Misiak, I., Poliwoda, A., Kazakova, A., Godovan, V., Halama, M., & Wieczorek, P. (2015). Research on acute toxicity and the behavioral effects of methanolic extract from psilocybin mushrooms and psilocin in mice. Toxins, 7(4), 1018–1029.CrossRefPubMedPubMedCentralGoogle Scholar
Article metrics

Related content

Interview with P. Roger Malina @ CreativeDisturbance.org

CogNovo Podcast - Marie Curie Fellow - Christopher Germann
Block
Chemical structure of DMT Molecule in 3D
Chemical structure of DMT Molecule in 3D
Chemical structure of DMT Molecule in 3D

Primary goals of research and innovation policy as defined by the European Comission:
Open Innovation, Open Science, Open to the World.

Cognitive NeuroPsy Podcast
On Quantum Cognition and DMT:
Can the axiomatic principles of quantum physics be applied to cognitive processes? And what is the role of N,N-Dimethyltryptamine in the human brain?

Christopher Germann and Prof. Roger Malina discuss Chris’ current work in the Cognovo PhD program, on quantum cognition which applies the mathematical formalisms of quantum theory to understanding cognitive processes. Chris is currently working on non-commutativity in decision theory, with laboratory experiments in visual decision making. He is also studying the role of the endogenous neurotransmitter DMT (N,N-Dimethyltryptamine) in perception and cognition.

www.CreativeDisturbance.org

Chris Germann is a Marie-Curie research fellow in the CogNovo doctoral programme at the Cognition Institute of Plymouth University, which is government-funded by the European Commission. Chris has broad interdisciplinary interests and he is momentarily mainly focusing on cognitive psychology and neuroscience. He is particularly interested in irrationality and decision making and the neuronal Serotonin system and its role in perception and cognition (for instance, creativity and neuroplasticity). Furthermore, philosophy of science and mind capture his deepest curiosity.

Website created with ♥ (and CSS3) by Christopher Germann
00:00 / 00:00
N,N-Dimethyltryptamine molecular structure in 3D

Click here to open a microdialysis study which detected DMT in the mammalian brain (i.e. pineal gland).

Quantum Physics

Wave-Function collapse
| ψ ⟩ = ∑ i c i | ϕ i ⟩ .

Electro-Chemical Brain Activity

Spreading activation in a neuronal network

PRESENTATION ON PSYCHOPHYSICS
PlayPlay
LISTEN TO THEMATICALLY RELATED PODCASTS
Prof. David Nichols
Waking Up to Psychedelic Medicine
Prof. Franz Vollenweider
Neurobiology of Psychedelics: Implication for Mood Disorders
SHARE
PhD Thesis: A psychophysical investigation of quantum cognition - An interdiciplinary synthesis
Transcending academic and epistemic boundaries: Psychoactive tryptamines and the frontiers of human exploration
5-methoxy-N,N-dimethyltryptamine: An ego-dissolving endogenous neurochemical catalyst of creativity

Barsuglia, J., Davis, A. K., Palmer, R., Lancelotta, R., Windham-Herman, A. M., Peterson, K., … Griffiths, R. R.. (2018). Intensity of mystical experiences occasioned by 5-MeO-DMT and comparison with a prior psilocybin study. Frontiers in Psychology

Plain numerical DOI: 10.3389/fpsyg.2018.02459
DOI URL
directSciHub download

Uthaug, M. V., Lancelotta, R., van Oorsouw, K., Kuypers, K. P. C., Mason, N., Rak, J., … Ramaekers, J. G.. (2019). A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms. Psychopharmacology

Plain numerical DOI: 10.1007/s00213-019-05236-w
DOI URL
directSciHub download

Davis, A. K., So, S., Lancelotta, R., Barsuglia, J. P., & Griffiths, R. R.. (2019). 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety. American Journal of Drug and Alcohol Abuse

Plain numerical DOI: 10.1080/00952990.2018.1545024
DOI URL
directSciHub download

Lima da Cruz, R. V., Moulin, T. C., Petiz, L. L., & Leão, R. N.. (2018). A Single Dose of 5-MeO-DMT Stimulates Cell Proliferation, Neuronal Survivability, Morphological and Functional Changes in Adult Mice Ventral Dentate Gyrus. Frontiers in Molecular Neuroscience

Plain numerical DOI: 10.3389/fnmol.2018.00312
DOI URL
directSciHub download

Davis, A. K., Barsuglia, J. P., Lancelotta, R., Grant, R. M., & Renn, E.. (2018). The epidemiology of 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption. Journal of Psychopharmacology

Plain numerical DOI: 10.1177/0269881118769063
DOI URL
directSciHub download

Lancelotta, R. L., & Davis, A. K.. (2020). Use of Benefit Enhancement Strategies among 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) Users: Associations with Mystical, Challenging, and Enduring Effects. Journal of Psychoactive Drugs

Plain numerical DOI: 10.1080/02791072.2020.1737763
DOI URL
directSciHub download

Riga, M. S., Lladó-Pelfort, L., Artigas, F., & Celada, P.. (2018). The serotonin hallucinogen 5-MeO-DMT alters cortico-thalamic activity in freely moving mice: Regionally-selective involvement of 5-HT1A and 5-HT2A receptors. Neuropharmacology

Plain numerical DOI: 10.1016/j.neuropharm.2017.11.049
DOI URL
directSciHub download

Sepeda, N. D., Clifton, J. M., Doyle, L. Y., Lancelotta, R., Griffiths, R. R., & Davis, A. K.. (2021). Inhaled 5-methoxy-N,N-dimethyltryptamine: Supportive context associated with positive acute and enduring effects. Journal of Psychedelic Studies

Plain numerical DOI: 10.1556/2054.2020.00143
DOI URL
directSciHub download

Sherwood, A. M., Claveau, R., Lancelotta, R., Kaylo, K. W., & Lenoch, K.. (2020). Synthesis and Characterization of 5-MeO-DMT Succinate for Clinical Use. ACS Omega

Plain numerical DOI: 10.1021/acsomega.0c05099
DOI URL
directSciHub download

Dakic, V., Minardi Nascimento, J., Costa Sartore, R., MacIel, R. D. M., De Araujo, D. B., Ribeiro, S., … Rehen, S. K.. (2017). Short term changes in the proteome of human cerebral organoids induced by 5-MeO-DMT. Scientific Reports

Plain numerical DOI: 10.1038/s41598-017-12779-5
DOI URL
directSciHub download

Ermakova, A. O., Dunbar, F., Rucker, J., & Johnson, M. W.. (2021). A narrative synthesis of research with 5-MeO-DMT. Journal of Psychopharmacology

Plain numerical DOI: 10.1177/02698811211050543
DOI URL
directSciHub download

Riga, M. S., Soria, G., Tudela, R., Artigas, F., & Celada, P.. (2014). The natural hallucinogen 5-MeO-DMT, component of Ayahuasca, disrupts cortical function in rats: Reversal by antipsychotic drugs. International Journal of Neuropsychopharmacology

Plain numerical DOI: 10.1017/S1461145714000261
DOI URL
directSciHub download

Winne, J., Boerner, B. C., Malfatti, T., Brisa, E., Doerl, J., Nogueira, I., … Leão, R. N.. (2020). Anxiety-like behavior induced by salicylate depends on age and can be prevented by a single dose of 5-MeO-DMT. Experimental Neurology

Plain numerical DOI: 10.1016/j.expneurol.2020.113175
DOI URL
directSciHub download

Lima da Cruz, R. V., Moulin, T. C., Petiz, L. L., & Leão, R. N.. (2019). Corrigendum: A single dose of 5-MeO-DMT stimulates cell proliferation, neuronal survivability, morphological and functional changes in adult mice ventral dentate gyrus (Frontiers in molecular neuroscience, (2018), 11, 10.3389/fnmol.2018.00312). Frontiers in Molecular Neuroscience

Plain numerical DOI: 10.3389/fnmol.2019.00079
DOI URL
directSciHub download

Halberstadt, A. L., Nichols, D. E., & Geyer, M. A.. (2012). Behavioral effects of α,α,β,β-tetradeutero-5-MeO-DMT in rats: Comparison with 5-MeO-DMT administered in combination with a monoamine oxidase inhibitor. Psychopharmacology

Plain numerical DOI: 10.1007/s00213-011-2616-6
DOI URL
directSciHub download

Uthaug, M. V., Lancelotta, R., Ortiz Bernal, A. M., Davis, A. K., & Ramaekers, J. G.. (2020). A comparison of reactivation experiences following vaporization and intramuscular injection (IM) of synthetic 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting. Journal of Psychedelic Studies

Plain numerical DOI: 10.1556/2054.2020.00123
DOI URL
directSciHub download

Germann, C. B.. (2019). 5-Methoxy-N,N-dimethyltryptamine: An Ego-Dissolving Endogenous Neurochemical Catalyst of Creativity. Activitas Nervosa Superior

Plain numerical DOI: 10.1007/s41470-019-00063-y
DOI URL
directSciHub download

Krebs-Thomson, K., Ruiz, E. M., Masten, V., Buell, M., & Geyer, M. A.. (2006). The roles of 5-HT1A and 5-HT2 receptors in the effects of 5-MeO-DMT on locomotor activity and prepulse inhibition in rats. Psychopharmacology

Plain numerical DOI: 10.1007/s00213-006-0566-1
DOI URL
directSciHub download

Barsuglia, J. P., Polanco, M., Palmer, R., Malcolm, B. J., Kelmendi, B., & Calvey, T.. (2018). A case report SPECT study and theoretical rationale for the sequential administration of ibogaine and 5-MeO-DMT in the treatment of alcohol use disorder. In Progress in Brain Research

Plain numerical DOI: 10.1016/bs.pbr.2018.08.002
DOI URL
directSciHub download

Schwelm, H. M., Zimmermann, N., Scholl, T., Penner, J., Autret, A., Auwärter, V., & Neukamm, M. A.. (2021). Qualitative and Quantitative Analysis of Tryptamines in the Poison of Incilius alvarius (Amphibia: Bufonidae) . Journal of Analytical Toxicology

Plain numerical DOI: 10.1093/jat/bkab038
DOI URL
directSciHub download

Halberstadt, A. L.. (2016). Behavioral and pharmacokinetic interactions between monoamine oxidase inhibitors and the hallucinogen 5-methoxy-N,N-dimethyltryptamine. Pharmacology Biochemistry and Behavior

Plain numerical DOI: 10.1016/j.pbb.2016.01.005
DOI URL
directSciHub download

Riga, M. S., Bortolozzi, A., Campa, L., Artigas, F., & Celada, P.. (2016). The serotonergic hallucinogen 5-methoxy-N,N-dimethyltryptamine disrupts cortical activity in a regionally-selective manner via 5-HT1A and 5-HT2A receptors. Neuropharmacology

Plain numerical DOI: 10.1016/j.neuropharm.2015.10.016
DOI URL
directSciHub download

Shen, H.-W., Jiang, X.-L., C. Winter, J., & Yu, A.-M.. (2011). Psychedelic 5-Methoxy-N,N-Dimethyltryptamine: Metabolism, Pharmacokinetics, Drug Interactions, and Pharmacological Actions. Current Drug Metabolism

Plain numerical DOI: 10.2174/138920010794233495
DOI URL
directSciHub download

Jiang, X. L., Shen, H. W., & Yu, A. M.. (2016). Modification of 5-methoxy-N,N-dimethyltryptamine-induced hyperactivity by monoamine oxidase A inhibitor harmaline in mice and the underlying serotonergic mechanisms. Pharmacological Reports

Plain numerical DOI: 10.1016/j.pharep.2016.01.008
DOI URL
directSciHub download

Jiang, X. L., Shen, H. W., Mager, D. E., Schmidt, S., & Yu, A. M.. (2016). Development of a mechanism-based pharmacokinetic/pharmacodynamic model to characterize the thermoregulatory effects of serotonergic drugs in mice. Acta Pharmaceutica Sinica B

Plain numerical DOI: 10.1016/j.apsb.2016.07.007
DOI URL
directSciHub download

Germann, C. B.. (2019). 5-methoxy-N,N-dimethyltryptamine: An ego-dissolving endogenous neurochemical catalyst of creativity. BioRxiv 578435

Plain numerical DOI: 10.1101/578435
DOI URL
directSciHub downloadURL: https://www.biorxiv.org/content/10.1101/578435v2
Truncated URL: https://t.co/LDkVtS8WqA
PDF: https://www.biorxiv.org/content/biorxiv/early/2019/03/17/578435.full.pdf
DOI: https://doi.org/10.1101/578435
Stats: https://rxivist.org/papers/46248
Google Scholar: https://scholar.google.com/scholar?cluster=8867435362829874238
Europe PMC: https://europepmc.org/abstract/ppr/ppr73330
ResearchGate: https://www.researchgate.net/publication/335329415_5-Methoxy-NN-dimethyltryptamine_An_Ego-Dissolving_Endogenous_Neurochemical_Catalyst_of_Creativity

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Leave a Reply